rfhg_26714.1

Basic information about the TSS

---

TSS ID: rfhg_26714.1 Species: human Chr: chr2		Start: 55050387 End: 55050397 Strand: -
Source datasets	DRA013844
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3125763,EH38E1999192)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000402434.6:11 BC071848:11 GeneID: 57142 HGNC/MGI_ID: HGNC:14085 UniProt_ID: F8W914 Q6IPN0 Nearer transcript ids and distances: AB015639:21 AK130812:28 BC152425:-37 AB020693:-37 AF148537:-44 AF148538:-44 ENST00000337526.11:-54 NM_020532.5:-54 NM_207520.2:-54 NM_153828.3:-54 BC012619:-54 AK098385:-54 AK129806:-60 AF132047:-82 BC010737:82 AB384033:85 AM393104:85 AM393557:85 AF320999:87 AJ251383:87 AJ251384:87 CU687182:87 BC026788:-89 KJ894399:89 KJ894400:89 BC012335:-99 AK075039:-134 ENST00000317610.11:-147 ENST00000357732.8:-147 AY102277:-147 AY102278:-147 AY102279:-147 AB040462:-147 AB040463:-147 BC016165:-150 BC150182:-151 BC152555:-151 BC068991:-151 ENST00000394611.6:-201 NM_001321860.1:-201 AY123246:-201 ENST00000404909.5:-431 AY123245:-431 view more...

Gene_name: reticulon 4 Gene_symbol: RTN4 Gene_synonyms: ASY KIAA0886 NOGO NSP-CL Gene_source: HGNC:14085

TATA-Box annotation

---

Distance to TSS:	59
Nearest PromoterID:	NM_020532
Entrez ID:	57142
Nearest Unigene:	Hs.637850
Nearest Refseq:	NM_007008
Nearest Ensembl:	ENSG00000115310
Gene Name:	reticulon 4
Gene Alias:	ASY|NI220/250|NOGO|NSP|NSP-CL|Nbla00271|Nbla10545|RTN-X|RTN4-A|RTN4-B1|RTN4-B2|RTN4-C
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.545455
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RTN4 p2@RTN4 p4@RTN4 p5@RTN4 p6@RTN4 p7@RTN4 p8@RTN4 p9@RTN4 p10@RTN4
Sample		p1@RTN4	p2@RTN4	p4@RTN4	p5@RTN4	p6@RTN4	p7@RTN4	p8@RTN4	p9@RTN4	p10@RTN4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	33.31	34.09	0.19	0.97	2.53	2.34	2.14	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	43.30	37.63	0.00	2.23	1.82	1.21	1.62	0.40	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.55	32.02	0.00	3.67	1.74	1.16	2.12	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	35.14	37.84	0.00	2.91	0.42	2.08	1.46	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	37.12	33.74	0.22	0.90	2.70	1.35	1.35	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	38.96	41.09	0.39	3.29	1.94	2.52	2.13	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	42.27	35.30	0.44	4.14	2.40	3.27	1.31	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	28.10	28.10	0.24	1.94	1.45	1.70	1.70	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	34.84	35.05	0.00	3.21	1.50	1.92	2.56	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.92	38.83	0.00	0.58	1.74	1.74	2.32	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.51	31.93	0.00	2.02	2.43	0.81	3.23	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	34.15	38.62	0.41	0.41	2.03	4.88	4.47	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	84.46	72.54	0.00	13.38	4.84	3.55	8.70	0.00	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	82.99	56.08	0.60	12.78	4.36	3.61	6.47	0.00	1.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	64.55	65.65	0.44	9.22	1.98	3.95	8.78	0.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	59.10	63.63	0.75	8.55	3.27	3.52	8.30	0.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	65.74	47.39	0.44	7.43	3.06	2.18	8.30	0.00	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	73.82	59.90	0.42	5.91	4.64	4.22	5.48	0.00	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	61.31	50.12	0.53	11.73	6.40	1.60	4.80	0.00	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	70.71	68.75	0.30	11.88	4.36	2.41	7.67	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	82.20	73.37	0.13	12.96	4.01	4.14	6.28	0.13	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	70.95	59.90	0.52	11.22	2.93	3.45	7.60	0.00	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	62.43	56.49	0.13	10.60	3.62	2.33	6.08	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	61.88	71.59	0.49	9.46	4.61	2.67	6.07	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	69.40	59.60	0.26	7.74	3.87	4.13	4.90	0.00	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	65.52	63.62	0.00	10.44	6.01	3.17	9.18	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	64.84	50.55	0.00	9.89	4.40	4.40	6.04	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	94.30	74.73	0.47	11.08	3.77	4.01	6.37	0.00	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	77.05	61.54	0.16	13.57	4.52	2.58	6.62	0.00	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	67.14	55.19	0.72	8.87	3.80	3.98	6.51	0.00	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	68.66	56.52	0.42	10.89	5.23	4.81	6.70	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	70.73	61.74	0.59	11.72	1.56	3.91	8.40	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	84.83	59.93	0.84	16.88	4.01	3.17	6.54	0.00	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	99.62	46.02	0.33	13.36	5.44	4.95	4.29	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	69.75	60.02	0.00	10.66	4.49	3.37	7.85	0.00	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	77.42	72.63	0.00	9.39	3.64	3.64	6.90	0.00	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	70.72	62.95	0.41	12.06	4.09	4.70	6.34	0.00	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	64.88	55.21	0.81	7.86	3.83	3.22	6.85	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	71.58	56.72	1.08	9.99	3.24	3.24	6.21	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	63.14	62.66	0.48	7.92	3.12	4.32	5.28	0.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	75.75	64.23	0.24	11.76	3.76	4.71	5.18	0.00	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	90.33	48.60	0.44	10.69	6.00	3.81	5.71	0.00	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	73.81	62.21	0.00	12.02	3.80	3.80	7.17	0.00	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	80.42	66.78	0.52	13.29	4.72	3.85	9.27	0.17	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	76.70	68.06	0.80	8.83	3.61	3.01	8.63	0.00	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	75.38	63.75	0.47	10.24	4.65	3.72	6.75	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	71.73	59.74	0.48	16.31	5.04	5.52	6.24	0.00	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	85.24	77.79	0.30	10.13	2.38	4.47	7.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	75.16	71.33	0.24	10.77	6.46	5.51	8.38	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	78.65	61.87	0.00	15.16	4.04	6.07	8.09	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	85.47	58.62	0.20	12.30	5.12	4.71	4.92	0.00	2.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	74.27	79.61	0.22	9.34	4.45	5.56	7.12	0.00	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	349.80	97.95	0.00	0.00	41.98	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	63.16	63.87	0.00	7.81	2.13	3.55	3.55	0.00	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	57.00	49.71	0.00	5.96	5.63	5.30	4.64	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	174.50	54.53	0.00	8.39	5.87	7.55	5.03	0.00	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	85.42	50.06	0.46	5.97	6.43	3.67	4.59	0.00	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	55.10	51.53	0.00	7.45	3.57	4.21	2.92	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	48.82	54.60	0.00	6.42	4.18	1.61	2.57	0.00	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	76.70	64.12	0.00	10.06	3.46	5.66	5.97	0.00	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.01	40.19	0.00	7.05	2.12	3.53	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.67	59.44	0.00	7.29	5.05	2.24	3.36	0.00	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	199.04	107.48	0.00	11.94	8.76	7.17	6.37	0.00	19.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	81.88	66.25	0.00	8.15	5.10	3.06	5.44	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	64.66	76.03	0.00	6.82	5.20	2.27	6.17	0.00	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	61.06	53.25	0.00	8.87	3.55	2.48	3.19	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	404.10	80.82	0.00	16.16	16.16	0.00	0.00	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	252.72	110.56	0.00	31.59	15.79	0.00	0.00	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	73.61	40.46	0.00	9.75	0.98	3.90	2.44	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	74.88	33.72	0.00	12.89	3.97	6.45	1.49	0.00	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	73.65	39.87	0.00	6.57	3.28	2.35	0.47	0.00	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	107.64	43.39	0.00	12.59	6.29	6.95	1.99	0.00	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	81.36	25.37	0.00	16.09	3.40	3.71	1.24	0.00	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	83.77	39.44	0.00	14.98	4.89	5.20	0.92	0.00	3.36
Adipocyte - breast, donor1	11376-118A8	269.73	25.34	0.63	59.08	28.51	29.14	2.22	0.00	1.58
Adipocyte - breast, donor2	11327-117E4	286.68	44.92	19.89	57.75	23.74	21.66	2.41	1.12	5.29
Adipocyte - omental, donor1	11473-119C6	352.42	37.66	10.43	65.90	37.02	42.62	2.42	0.51	1.91
Adipocyte - omental, donor2	11474-119C7	227.99	26.16	4.48	14.95	14.20	15.70	3.74	0.00	5.98
Adipocyte - omental, donor3	11475-119C8	229.08	37.51	13.06	16.08	18.09	14.07	1.67	1.34	3.35
Adipocyte - perirenal, donor1	11476-119C9	243.07	32.54	1.28	19.14	10.21	15.31	0.64	0.00	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	131.94	19.79	0.00	14.29	7.70	6.60	3.30	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	135.94	16.71	1.35	19.87	9.03	12.19	1.35	0.00	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	206.10	36.67	8.17	33.02	10.08	10.08	1.22	0.52	2.26
Adipocyte differentiation, day04, donor1	13019-139D4	164.87	58.67	0.20	21.32	12.13	9.19	3.91	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	98.83	58.68	0.26	13.90	6.18	5.66	4.63	0.00	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	215.21	53.52	0.00	29.27	18.40	21.47	3.07	0.00	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	207.50	68.19	1.18	38.80	19.40	18.22	6.47	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	242.18	67.40	76.89	30.24	19.22	12.15	2.82	5.79	1.05
Adipocyte differentiation, day08, donor2	13023-139D8	134.27	72.30	6.13	20.98	10.65	11.30	4.52	0.00	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	199.41	58.65	9.06	20.26	17.60	6.40	1.07	0.00	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	201.43	55.64	8.35	17.25	10.57	16.14	2.23	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	200.04	56.56	73.61	23.29	11.64	12.06	2.91	2.91	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	155.97	47.22	18.08	14.07	10.55	7.03	2.51	0.50	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	233.98	65.78	20.62	31.74	21.27	19.63	1.64	1.64	2.62
Adipocyte differentiation, day12, donor4	13030-139E6	178.42	52.98	42.32	27.40	15.22	14.92	2.13	2.44	2.13
Alveolar Epithelial Cells, donor1	11510-119G7	133.26	41.33	0.00	20.55	10.83	8.18	1.77	0.00	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	61.68	20.08	0.00	4.30	2.87	3.94	1.08	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	70.68	17.97	0.00	4.79	2.40	1.20	1.20	0.00	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	159.22	31.66	0.00	17.09	7.56	9.18	0.72	0.00	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	127.19	48.53	0.00	10.04	1.67	10.04	1.67	0.00	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	170.73	34.93	0.00	24.24	14.38	11.92	3.08	0.00	1.85
Anulus Pulposus Cell, donor1	11248-116E6	138.46	63.51	0.00	17.74	10.64	6.06	4.00	0.00	1.37
Anulus Pulposus Cell, donor2	11463-119B5	193.72	69.06	0.00	18.37	10.04	7.84	2.69	0.00	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	161.30	26.06	0.90	12.58	13.48	16.17	2.25	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	219.68	31.26	0.00	19.54	15.63	26.05	1.30	0.00	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	124.13	19.26	0.00	23.54	17.12	21.40	2.14	0.00	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	186.83	28.70	0.30	14.65	15.54	20.03	1.79	0.00	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	153.02	21.50	0.00	22.76	13.91	12.65	1.26	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	112.87	23.76	0.00	22.44	12.54	13.86	0.00	0.00	5.28
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	181.94	24.37	0.00	14.62	12.67	15.92	0.32	0.00	3.25
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	169.90	26.70	0.00	16.99	8.74	15.05	1.94	0.00	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	121.75	18.41	0.00	19.00	15.44	11.88	1.78	0.00	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	162.71	21.84	0.00	10.55	16.57	14.31	1.88	0.00	4.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	165.45	21.04	0.00	17.42	13.06	15.24	2.18	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	115.35	10.03	0.00	18.81	21.31	17.55	1.25	1.25	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	166.71	25.53	0.00	44.15	19.27	25.70	1.48	0.00	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	173.33	19.11	0.00	6.82	23.20	19.11	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	81.58	14.78	0.00	22.02	7.99	12.97	1.81	0.00	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	167.17	20.36	0.00	17.15	11.79	13.93	1.61	0.54	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	168.15	27.40	0.00	25.88	11.71	18.52	1.70	0.00	3.40
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	148.08	24.86	0.00	29.13	13.63	18.18	0.80	0.00	4.01
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	165.83	20.48	0.00	12.68	13.66	16.58	0.98	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	146.95	32.18	0.00	21.40	12.77	16.42	1.82	0.00	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	90.05	21.61	0.00	22.81	13.21	13.21	1.20	0.00	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	169.93	17.70	0.00	10.62	3.54	35.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	154.21	32.25	0.00	28.13	13.55	14.75	1.54	0.00	2.06
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	104.87	16.78	0.00	25.17	8.39	20.97	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	172.81	17.96	0.00	13.11	13.11	18.45	1.46	0.00	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	170.75	30.36	0.00	22.01	15.18	17.45	0.76	0.00	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	134.46	26.65	0.00	20.59	20.59	16.96	1.21	0.00	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	171.58	23.94	0.00	14.82	14.25	13.11	2.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	144.51	32.92	0.00	22.87	14.75	17.74	1.50	0.00	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	130.34	25.55	0.00	29.16	12.65	19.36	2.06	0.00	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	171.73	28.15	0.00	14.08	14.08	16.89	0.94	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	149.84	34.73	0.00	24.44	10.93	17.36	1.29	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	94.18	25.68	0.00	20.69	12.84	7.85	0.71	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	171.39	25.15	0.00	12.28	10.53	15.21	0.00	0.00	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	150.84	25.59	0.00	24.69	12.34	21.08	1.20	0.00	3.01
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	105.73	36.83	0.00	19.01	11.88	13.07	1.19	0.00	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	186.64	22.38	0.00	19.33	15.77	22.89	2.03	0.00	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	159.69	27.76	0.00	25.47	15.79	15.79	2.04	0.00	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	108.01	21.60	0.00	22.24	11.44	11.44	1.27	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	188.58	25.89	0.00	15.10	13.81	21.58	0.86	0.00	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	145.64	26.88	0.00	20.96	14.18	16.09	1.69	0.00	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	112.51	29.00	0.00	22.62	11.31	14.21	1.74	0.00	1.74
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	152.10	28.34	0.00	14.17	16.06	20.78	2.83	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	140.88	29.16	0.00	24.75	13.39	16.10	1.36	0.00	2.54
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	127.40	25.48	0.00	18.53	13.90	13.90	2.32	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	183.79	14.79	0.00	8.45	14.79	16.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	141.94	28.95	0.00	17.15	12.22	14.37	2.36	0.00	2.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	109.50	27.07	0.00	18.65	13.24	20.46	4.81	0.00	4.81
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	177.87	17.50	0.00	8.75	10.93	16.04	0.73	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	148.73	25.06	0.00	23.91	9.88	11.26	2.30	0.00	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	132.62	35.70	0.00	20.40	12.75	28.05	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	95.85	19.32	0.00	22.88	10.93	16.53	0.76	0.00	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	163.29	30.35	0.00	25.19	13.42	20.02	1.24	0.00	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	121.18	31.21	0.00	27.85	10.10	12.55	1.53	0.00	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	163.00	24.86	0.00	18.16	14.34	24.38	1.43	0.00	4.30
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	141.03	26.39	0.00	21.95	8.65	15.08	1.55	0.00	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	125.12	19.84	0.00	19.84	13.73	16.78	1.53	0.00	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	145.67	19.94	0.00	15.51	17.17	19.39	1.11	0.00	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	136.90	27.27	0.00	20.92	11.39	15.09	1.59	0.00	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	103.22	19.99	0.00	21.44	11.63	13.45	0.00	0.00	1.45
Astrocyte - cerebellum, donor1	11500-119F6	84.25	53.43	0.00	15.84	6.63	6.63	4.30	0.00	1.35
Astrocyte - cerebellum, donor2	11580-120F5	98.59	65.38	0.00	16.09	6.33	2.74	3.94	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	42.79	59.99	0.00	9.44	7.13	1.68	5.03	0.00	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	95.16	116.78	0.35	23.70	20.22	6.27	9.06	0.00	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	127.96	120.36	0.00	34.30	16.18	11.00	8.74	0.00	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	177.95	221.20	0.15	40.12	26.85	11.78	32.52	0.00	3.58
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	59.52	24.89	2.87	15.02	2.87	2.41	3.67	0.11	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	61.14	27.56	2.38	13.28	3.26	3.01	3.88	0.25	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	60.99	28.11	1.71	15.36	3.64	2.39	3.30	0.00	0.68
Basophils, donor1	12241-129G9	51.52	13.60	2.88	7.06	4.45	4.18	1.31	0.26	0.00
Basophils, donor2	12242-129H1	54.84	9.74	6.86	15.87	6.13	5.05	1.08	0.36	0.36
Basophils, donor3	12243-129H2	54.83	13.82	5.59	11.02	5.00	3.23	1.32	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	78.26	10.78	0.86	11.00	4.53	2.80	0.86	0.00	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	54.86	7.77	0.00	5.94	3.66	2.29	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	150.64	28.69	0.00	7.17	7.17	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	53.98	8.79	1.26	5.65	6.90	6.28	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	94.83	17.88	0.00	13.31	6.65	4.99	0.62	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	68.40	15.43	0.92	8.98	5.07	4.15	0.23	0.00	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	75.76	28.43	2.52	2.70	2.16	1.62	0.90	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	31.12	25.25	0.00	8.86	2.99	5.87	4.12	0.00	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	16.30	7.69	0.00	8.62	1.40	1.63	0.47	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	44.13	32.94	1.60	7.99	3.52	1.92	4.80	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	41.37	0.00	10.34	0.00	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	34.94	14.65	2.25	7.33	3.94	5.64	2.82	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	70.16	19.49	0.93	10.95	6.68	4.64	0.74	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	49.18	19.10	2.41	13.83	4.17	3.73	1.98	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	55.76	93.12	37.64	11.04	8.21	5.66	8.49	0.28	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	83.02	76.19	31.08	13.27	5.69	6.07	6.07	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	84.82	101.58	41.42	12.82	9.53	4.60	7.56	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	151.20	30.50	2.31	18.79	15.18	10.55	2.02	0.14	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	114.36	33.80	1.51	13.28	12.67	8.15	2.72	0.30	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	153.74	45.01	0.71	20.61	13.50	10.66	4.03	0.24	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	123.37	30.97	1.34	10.55	12.05	6.53	3.18	0.00	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	125.86	46.09	0.00	9.94	9.11	5.80	1.66	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	143.55	46.36	2.73	10.41	7.69	6.69	3.72	0.25	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	195.60	52.08	2.15	16.45	19.38	9.40	3.33	0.59	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	176.98	53.41	1.42	10.33	15.49	6.94	2.85	0.18	2.67
CD14+ monocytes - treated with BCG, donor3	11880-125C8	145.81	35.47	1.52	14.80	15.67	9.36	2.61	0.00	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	108.87	34.42	1.17	7.26	7.73	5.38	2.58	0.23	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	93.46	48.05	0.53	5.81	5.28	2.11	2.11	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	87.64	31.06	0.00	1.11	7.77	2.22	4.44	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	138.04	28.71	1.78	13.68	10.56	7.44	2.08	0.45	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	131.30	35.52	1.00	12.17	11.37	7.38	2.00	0.00	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	99.73	23.94	0.83	13.32	5.62	6.45	1.87	0.00	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	175.71	36.61	1.60	14.18	18.76	7.78	1.37	0.23	2.29
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	130.07	42.30	1.36	9.95	12.44	7.92	2.71	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	126.57	26.62	1.31	14.40	9.60	6.55	1.31	1.31	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	201.47	49.23	1.88	20.98	21.52	12.37	2.42	0.27	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	173.94	61.58	1.92	15.00	16.40	7.68	3.66	0.17	2.44
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	187.69	59.76	1.26	17.67	12.62	11.78	2.10	0.42	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	170.85	33.99	1.10	14.51	11.76	8.63	0.55	0.18	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	175.78	48.96	0.35	10.92	11.27	5.99	1.76	0.35	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	172.86	43.00	0.00	12.72	13.16	6.58	2.19	0.00	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	184.31	53.71	1.57	12.55	16.39	5.93	3.66	0.52	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	153.87	57.98	1.86	8.55	10.04	5.95	4.46	0.00	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	154.12	46.99	2.16	12.29	12.50	7.11	2.59	0.00	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	147.83	30.30	2.87	11.47	12.28	6.55	3.28	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	104.54	30.60	0.70	7.42	9.50	4.87	0.93	0.23	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	88.16	20.65	0.46	9.51	7.42	4.87	0.46	0.23	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	56.89	21.36	1.31	4.14	3.27	2.18	1.31	0.00	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	84.54	23.33	1.85	7.39	6.24	3.46	1.15	0.23	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	40.51	25.13	2.17	6.07	2.38	2.17	1.30	0.00	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	106.20	40.64	0.16	9.97	5.61	4.52	2.18	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	90.12	31.96	0.17	9.43	7.51	3.67	2.10	0.00	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	82.94	41.25	0.89	11.82	4.01	2.68	1.78	0.22	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	71.70	27.05	0.51	6.89	5.61	1.79	2.30	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	99.68	33.37	0.88	8.56	7.25	3.07	1.76	0.00	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	63.16	32.42	2.11	5.26	2.95	1.68	1.89	0.00	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	12.19	0.00	18.29	4.06	2.03	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	17.63	10.85	0.00	11.53	2.71	2.71	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	17.61	9.32	1.04	14.50	4.14	5.18	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	25.05	12.79	3.20	13.33	4.80	2.67	3.73	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.05	12.33	1.61	8.04	3.75	2.14	2.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	8.42	2.11	7.72	3.51	6.32	4.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.04	13.33	0.00	10.20	6.27	3.14	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	9.23	2.64	10.55	0.00	0.00	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	16.44	7.40	1.64	10.68	0.00	1.64	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	15.23	13.06	0.73	5.80	0.73	2.18	3.63	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	19.69	11.61	0.50	4.54	1.01	4.54	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	31.92	12.93	4.44	5.66	2.83	0.81	1.62	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	25.57	17.98	2.40	4.39	1.60	2.40	2.80	0.40	0.80
CD34+ Progenitors, donor1	11545-120B6	28.11	18.07	2.01	10.04	2.01	5.02	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	35.39	15.17	5.06	3.37	5.06	2.81	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	43.59	31.19	7.89	6.01	3.01	2.25	4.13	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	44.65	29.54	8.12	8.57	2.25	2.03	3.38	0.90	0.23
CD4+ T Cells, donor1	11225-116C1	29.99	14.64	22.49	16.42	1.79	3.57	0.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	44.09	23.27	13.47	15.31	4.90	5.51	2.45	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	35.07	21.96	11.59	15.86	2.13	3.05	3.66	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	30.37	10.46	15.31	9.19	3.57	2.30	1.02	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.95	13.25	15.27	11.90	2.47	1.57	2.02	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	26.16	11.79	19.83	13.22	3.45	2.59	0.29	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	38.40	24.65	27.50	12.80	2.84	1.90	3.32	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	38.63	16.86	37.22	11.24	2.11	4.92	2.81	2.81	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	16.48	42.85	29.67	0.00	0.00	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	34.11	9.97	57.66	11.85	3.90	5.49	1.16	1.73	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.37	13.05	13.22	12.71	4.74	2.54	1.53	0.34	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.44	12.90	13.70	12.90	3.55	2.58	1.77	0.32	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	35.42	19.28	45.73	7.62	3.59	3.59	3.14	0.45	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	40.53	18.52	36.69	11.18	3.49	4.54	2.10	1.40	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	27.72	16.28	45.76	15.84	1.76	3.08	1.32	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	31.62	15.18	12.65	11.81	3.37	3.79	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.27	8.93	7.06	8.52	1.25	2.70	1.45	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.05	7.35	10.36	9.69	3.34	3.68	1.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	28.55	30.18	28.83	7.34	1.36	1.63	5.44	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	28.41	26.80	41.80	5.36	3.75	1.61	4.82	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	37.66	28.69	8.97	1.79	1.79	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.75	10.20	8.34	12.05	5.56	4.26	0.93	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	22.53	7.36	7.58	9.96	4.55	2.60	1.73	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	24.59	6.94	7.57	11.77	4.20	5.04	0.84	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	27.81	16.18	11.63	15.17	4.55	3.03	3.03	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	36.83	13.00	23.83	14.73	4.33	3.90	1.30	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	33.56	13.07	30.07	11.77	0.44	3.49	2.61	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	35.14	19.79	18.81	16.83	3.46	3.96	2.97	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.00	11.08	5.54	22.16	2.77	3.69	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	20.94	16.75	18.15	1.40	5.58	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	42.92	18.28	4.15	9.97	4.71	1.94	1.11	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	41.72	20.86	5.15	12.02	2.70	3.68	4.91	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	43.12	27.72	9.24	27.72	4.62	3.08	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	42.62	23.64	12.53	20.05	6.45	5.01	1.43	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	18.00	12.46	19.39	0.00	2.77	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	33.07	5.89	11.13	12.77	1.96	8.51	0.33	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	46.55	7.13	3.75	16.14	3.38	5.26	0.75	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	35.35	12.88	7.57	17.93	1.51	3.28	2.02	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	25.46	7.11	0.00	8.26	2.29	3.44	0.46	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.96	9.83	0.00	6.23	3.83	5.27	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.82	7.39	0.00	5.47	3.83	6.02	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.22	5.70	0.00	7.51	2.10	3.30	0.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	27.12	4.80	0.00	4.80	1.68	5.04	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.74	5.00	0.00	6.14	2.73	5.46	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.55	5.87	0.00	8.04	3.69	6.30	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	24.74	7.63	0.00	5.79	2.11	5.53	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	31.89	8.44	0.00	9.38	4.22	5.39	0.23	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	36.53	9.96	0.00	6.64	2.72	5.43	0.30	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	28.18	6.97	0.00	8.72	4.36	6.39	0.58	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	33.57	10.39	0.00	7.19	2.93	2.40	0.53	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	43.34	10.94	0.00	7.88	5.69	3.50	0.00	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	38.26	13.66	0.00	14.12	4.10	4.55	0.91	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	39.53	14.17	0.00	5.97	5.22	8.95	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.05	11.52	0.00	6.84	5.40	5.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	25.32	5.75	0.00	7.77	3.45	4.60	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.93	5.89	0.00	8.96	4.71	5.89	0.71	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	35.81	10.46	0.00	10.46	1.90	4.44	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.22	8.61	0.00	7.69	4.61	4.92	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.66	6.09	0.00	8.34	5.13	4.17	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	23.33	8.41	0.00	3.44	3.06	2.68	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.68	7.09	0.00	4.73	3.15	5.52	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	22.69	6.81	0.00	3.03	0.76	5.29	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.18	23.29	0.00	4.01	0.80	6.42	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	44.06	18.88	0.00	9.09	5.60	7.69	2.80	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	57.10	28.05	0.00	13.02	6.01	5.01	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	169.98	82.25	1.83	18.28	5.48	12.79	5.48	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	103.76	35.57	0.00	11.36	4.94	6.42	3.95	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	132.38	33.15	0.21	13.47	9.16	5.89	2.53	0.11	0.42
Chondrocyte - de diff, donor1	11261-116G1	183.39	27.39	1.04	19.07	12.48	15.60	1.04	0.00	1.73
Chondrocyte - de diff, donor2	11338-117F6	122.25	36.25	0.00	12.08	4.98	4.98	1.42	0.00	1.42
Chondrocyte - de diff, donor3	11410-118E6	159.86	39.82	0.57	23.67	10.24	7.05	2.28	0.00	2.05
Chondrocyte - re diff, donor2	11339-117F7	67.14	47.45	0.00	16.11	3.58	8.95	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	76.03	38.82	0.00	14.96	6.47	5.66	4.04	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	72.99	79.99	0.00	25.02	8.61	7.92	7.69	0.00	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	122.06	93.63	0.00	32.06	9.62	10.26	6.41	0.00	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	106.46	102.39	0.27	29.91	10.97	8.85	6.64	0.00	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	57.68	50.25	91.15	11.19	7.06	4.86	12.38	7.52	0.28
Corneal Epithelial Cells, donor1	11526-119I5	80.36	15.15	0.22	12.74	3.95	3.07	0.66	0.00	1.10
Corneal Epithelial Cells, donor2	11606-120I4	84.18	10.24	1.14	13.65	5.69	7.96	1.14	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	96.12	19.68	0.26	14.57	6.14	9.46	1.28	0.00	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	113.59	20.47	2.48	29.72	16.67	9.58	1.98	0.00	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	116.70	20.19	1.58	28.70	18.29	8.83	0.63	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	79.37	13.80	0.00	10.35	17.25	6.90	3.45	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	121.16	24.95	1.40	28.08	9.83	6.80	1.51	0.00	1.94
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.85	25.28	3.07	7.17	2.73	6.49	5.81	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	39.83	20.24	7.18	13.71	2.61	3.26	3.26	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.10	22.26	4.84	6.78	2.42	9.19	5.32	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	120.57	35.69	0.00	20.35	21.51	13.84	2.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	105.03	35.79	0.00	16.43	12.91	11.15	1.17	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	137.44	46.10	0.00	17.53	20.64	11.88	2.26	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	169.46	52.29	0.00	40.89	25.56	13.37	4.72	0.00	2.36
Endothelial Cells - Artery, donor1	11264-116G4	166.38	50.61	0.00	17.45	15.71	11.34	1.16	0.00	1.16
Endothelial Cells - Artery, donor2	11341-117F9	122.58	48.94	0.00	22.35	14.82	10.35	1.65	0.00	0.94
Endothelial Cells - Artery, donor3	11413-118E9	106.41	42.25	0.00	21.21	11.57	6.14	2.45	0.00	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	104.62	42.11	0.00	19.51	16.62	7.09	4.21	0.00	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	129.62	61.16	0.00	25.86	19.17	15.82	5.48	0.00	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	144.62	53.00	0.00	23.40	18.89	10.43	4.51	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	142.03	23.47	0.00	16.05	26.44	21.10	0.59	0.00	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	99.97	24.99	0.00	18.74	6.77	8.33	0.00	0.00	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	124.06	34.31	0.00	31.62	22.97	10.78	2.55	0.00	1.84
Endothelial Cells - Thoracic, donor1	11266-116G6	167.65	34.41	0.40	21.21	19.61	14.40	2.40	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	101.68	49.79	0.00	25.16	14.15	13.63	1.05	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	113.44	83.62	0.00	22.99	19.26	5.59	8.57	0.00	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	87.77	89.95	0.00	16.73	11.08	5.21	3.91	0.00	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	97.95	111.38	0.00	22.72	12.33	4.76	5.62	0.00	1.10
Endothelial Cells - Vein, donor1	11267-116G7	79.63	52.33	0.00	10.24	12.51	3.41	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	120.14	26.54	0.00	17.46	16.76	11.87	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	101.43	42.86	0.00	21.35	11.93	5.18	2.04	0.00	1.26
Eosinophils, donor1	12244-129H3	30.49	15.25	15.25	15.25	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	178.23	66.01	3.30	34.66	19.80	28.05	4.95	0.00	1.65
Eosinophils, donor3	12246-129H5	142.67	49.94	0.00	35.67	7.13	14.27	14.27	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	67.92	13.19	0.24	11.48	2.69	3.18	0.00	0.00	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	89.45	8.32	0.00	6.24	6.24	4.16	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	16.27	0.00	0.00	0.00	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	207.31	55.01	0.41	39.41	12.73	25.04	4.11	0.00	5.34
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	129.52	19.16	0.00	33.61	14.12	26.93	1.09	0.00	9.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	49.73	8.67	0.00	16.36	8.02	4.23	0.98	0.00	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	181.19	30.20	0.00	33.47	19.65	21.59	2.43	0.00	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	265.98	36.30	0.14	42.85	20.74	46.67	3.28	0.14	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	226.23	50.84	0.32	46.72	21.73	28.37	2.53	0.00	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	632.64	90.90	0.00	21.61	27.67	42.69	5.27	0.00	3.43
Fibroblast - Aortic Adventitial, donor3	11401-118D6	198.32	46.84	0.66	40.86	16.28	15.95	1.66	0.00	1.99
Fibroblast - Cardiac, donor1	11268-116G8	175.55	38.10	0.00	16.33	7.26	9.98	1.81	0.00	1.36
Fibroblast - Cardiac, donor2	11345-117G4	130.37	10.61	0.00	15.16	9.10	15.16	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	171.60	32.96	0.00	23.97	15.14	12.14	2.52	0.00	2.37
Fibroblast - Cardiac, donor4	11452-119A3	113.97	51.53	0.61	30.61	8.49	6.37	1.82	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	195.43	56.09	0.00	27.79	23.22	17.77	2.79	0.00	2.92
Fibroblast - Cardiac, donor6	11460-119B2	140.53	38.81	0.00	19.40	13.34	10.46	1.67	0.00	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	129.30	54.40	0.00	18.09	10.18	12.19	2.41	0.00	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	93.62	65.58	0.00	18.98	6.47	9.49	3.02	0.00	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	143.55	73.24	0.00	23.44	8.79	10.25	2.93	0.00	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	261.31	89.03	0.00	22.60	18.68	14.99	5.77	0.00	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	125.85	38.33	0.51	16.11	7.12	4.75	3.05	0.00	1.53
Fibroblast - Dermal, donor1	11269-116G9	270.47	33.57	0.23	48.83	23.48	32.63	1.41	0.00	1.88
Fibroblast - Dermal, donor2	11346-117G5	162.73	22.64	0.00	25.47	15.57	15.57	0.47	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	222.07	35.42	0.12	64.92	24.78	25.51	0.85	0.00	3.63
Fibroblast - Dermal, donor4	11450-119A1	174.99	63.08	0.23	22.61	9.95	7.01	2.49	0.00	1.36
Fibroblast - Dermal, donor5	11454-119A5	204.28	65.07	0.00	28.09	15.00	12.56	1.92	0.00	1.40
Fibroblast - Dermal, donor6	11458-119A9	191.98	57.17	0.32	26.64	12.51	11.69	2.44	0.00	2.27
Fibroblast - Gingival, donor1	11237-116D4	188.86	44.77	0.00	28.74	14.78	13.74	2.08	0.00	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	357.89	60.52	1.05	58.43	26.20	30.39	3.93	0.00	3.41
Fibroblast - Gingival, donor2	11318-117D4	143.64	67.47	0.00	22.93	10.15	5.80	3.56	0.00	2.11
Fibroblast - Gingival, donor3	11394-118C8	308.04	99.49	0.00	41.48	20.98	14.50	6.28	0.00	1.16
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	308.55	92.46	0.00	51.94	34.28	27.01	5.19	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	345.18	85.81	0.18	43.52	24.32	23.08	6.34	0.00	2.11
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	160.42	43.96	0.47	35.39	11.22	11.85	2.96	0.16	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	248.55	46.79	0.00	47.60	23.26	20.83	2.16	0.00	2.30
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1082.28	146.80	0.00	224.43	117.51	140.09	13.76	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	204.30	47.97	0.58	40.95	18.57	19.60	3.51	0.00	2.05
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	193.49	37.91	0.27	35.04	16.09	15.68	2.18	0.14	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	309.23	64.17	0.11	69.98	25.34	30.28	3.73	0.22	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	270.44	76.16	0.00	40.79	21.72	18.93	6.16	0.00	2.93
Fibroblast - Lung, donor1	11270-116H1	133.22	31.27	0.00	21.75	6.80	13.59	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	265.60	49.24	0.00	31.34	17.91	23.87	1.49	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	200.91	53.81	0.00	45.16	17.94	12.24	3.38	0.00	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	478.99	50.81	0.00	29.99	24.16	26.66	2.50	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	261.54	30.77	0.00	25.18	20.98	23.78	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	172.40	26.59	0.00	22.11	12.59	10.08	0.56	0.00	0.84
Fibroblast - Mammary, donor1	11540-120B1	251.70	45.47	0.00	36.13	15.43	16.24	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	175.75	27.96	0.00	11.98	15.98	19.97	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	208.47	89.34	0.00	23.83	29.78	23.83	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	107.07	46.75	0.00	16.88	10.09	9.12	3.30	0.00	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	212.35	140.91	0.00	28.67	14.71	6.52	8.19	0.00	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	291.61	68.54	0.00	53.55	17.75	32.43	1.53	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	305.30	86.25	0.00	41.60	20.61	18.32	6.11	0.00	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	261.35	47.25	0.54	45.09	19.17	16.20	1.89	0.27	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	313.25	104.49	0.23	50.45	25.75	23.89	8.23	0.00	1.97
Fibroblast - Pulmonary Artery, donor1	11250-116E8	98.26	24.43	0.00	21.00	13.15	9.73	1.11	0.00	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	143.66	41.86	0.00	33.12	10.97	13.41	2.03	0.00	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	111.59	40.09	0.00	14.03	11.36	12.70	3.34	0.00	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	153.40	42.30	0.00	21.35	9.09	10.67	1.19	0.00	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	459.80	87.12	0.00	14.29	18.06	35.13	3.97	0.20	2.78
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	162.34	28.24	0.53	14.03	8.53	7.10	1.60	0.18	1.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	178.76	18.33	1.18	25.23	11.23	13.60	1.58	0.20	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	415.48	70.10	0.00	17.75	18.95	31.89	2.11	0.00	2.71
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	203.38	31.63	0.22	16.52	12.31	13.93	1.08	0.00	1.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	347.47	57.45	0.51	9.87	10.38	15.69	1.27	0.00	2.02
Fibroblast - skin normal, donor1	11553-120C5	205.26	30.52	0.16	28.71	12.96	16.41	0.98	0.00	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	393.60	56.54	2.61	47.52	21.45	40.90	1.80	0.40	3.01
Fibroblast - skin normal, donor2	11561-120D4	214.29	24.41	1.31	22.91	11.75	18.08	1.11	0.10	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	345.16	67.40	0.60	9.67	16.32	26.90	1.51	0.60	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	164.37	28.08	0.17	27.26	10.27	12.84	2.24	0.17	1.24
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	140.01	35.56	0.68	8.21	4.96	6.50	3.42	0.00	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	459.15	87.03	1.97	17.41	20.36	31.53	3.94	0.00	6.57
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	207.93	31.85	0.75	21.41	13.32	25.78	1.49	0.00	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	198.87	38.80	0.34	21.93	10.96	13.33	1.52	0.17	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	196.97	20.86	0.16	21.95	12.86	10.19	0.94	0.00	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	664.79	66.48	22.16	265.92	66.48	132.96	0.00	0.00	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	138.57	24.40	1.74	10.46	8.72	8.72	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	192.43	21.50	0.17	46.29	31.38	37.45	0.52	0.00	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	168.38	23.94	0.52	45.02	22.12	20.56	0.52	0.00	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	189.85	30.66	0.26	48.80	18.65	27.08	3.32	0.00	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	36.75	94.93	0.00	13.78	6.12	9.19	23.73	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.28	95.71	0.00	21.06	6.38	15.95	15.95	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	37.08	113.53	0.00	17.12	4.28	3.99	23.11	0.00	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	22.34	88.79	0.00	57.63	14.34	8.55	22.34	0.00	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.52	98.87	0.46	22.15	7.99	5.71	23.97	0.00	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	33.68	136.91	0.40	19.42	6.54	4.76	33.48	0.00	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	18.77	88.29	0.00	44.14	12.42	8.19	17.97	0.00	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.48	123.28	0.33	20.22	6.20	4.57	25.11	0.00	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	45.11	131.78	0.00	19.02	7.52	4.42	24.32	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	58.37	78.86	0.00	14.27	4.38	5.09	15.26	0.00	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	64.03	101.10	0.12	14.41	6.28	4.31	16.25	0.00	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	43.52	77.90	0.00	19.88	4.84	5.91	20.95	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	145.82	115.10	0.00	20.94	12.14	9.54	17.59	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	180.65	148.81	0.00	29.76	16.89	9.41	17.72	0.00	2.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	109.58	135.60	0.20	24.40	11.99	7.32	21.75	0.00	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	84.43	84.65	0.23	18.48	11.87	4.11	15.52	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	134.53	91.18	0.00	26.16	13.70	8.72	13.83	0.00	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	127.87	131.58	0.00	30.16	16.39	8.96	15.52	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	50.53	92.49	0.30	11.23	8.27	3.55	22.46	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	84.41	93.15	0.16	13.19	10.33	6.99	17.17	0.00	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	86.24	97.19	0.00	19.44	8.27	4.24	17.87	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	58.27	100.21	0.00	9.28	2.82	3.63	16.94	0.00	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	80.41	90.93	0.34	12.21	5.09	5.26	12.38	0.00	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	105.08	78.03	0.89	28.91	13.66	10.37	12.24	0.09	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	75.65	97.81	0.52	13.94	5.93	5.10	26.43	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.19	88.29	0.51	9.05	3.59	2.56	21.35	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	69.93	94.06	0.33	10.40	2.66	3.65	14.94	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	69.47	67.97	0.92	19.05	7.74	5.32	14.73	0.08	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	53.90	74.12	0.82	13.48	6.33	3.68	12.25	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	54.46	88.30	0.41	8.25	3.09	2.89	17.95	0.21	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	69.52	102.50	0.92	9.80	2.54	3.69	17.76	0.23	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	61.70	97.89	0.33	10.17	6.34	5.67	19.51	0.00	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	58.41	100.08	0.44	5.95	3.53	1.98	22.26	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	69.00	112.05	1.35	6.64	3.20	1.97	22.63	0.00	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	62.57	94.50	0.65	12.97	4.54	4.21	18.32	0.16	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	63.18	106.80	0.32	8.34	3.21	0.64	19.24	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	86.32	103.38	0.38	12.41	2.65	4.64	17.34	0.28	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	55.36	104.55	0.32	12.97	2.37	3.80	21.35	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	81.19	110.38	0.91	14.60	4.87	5.17	12.47	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	92.83	87.50	1.05	12.44	4.08	8.05	12.96	0.21	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	52.69	109.56	1.32	9.00	3.73	3.51	21.96	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	69.01	96.79	1.12	15.15	6.73	3.09	21.32	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	126.38	78.98	0.28	17.68	5.74	10.09	8.80	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	70.06	97.60	0.80	9.89	6.15	4.55	11.23	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	110.01	95.02	0.15	21.11	8.72	10.40	9.49	0.00	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	115.55	81.87	0.26	12.57	6.35	10.49	8.03	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	61.26	127.95	1.08	7.32	3.25	4.34	18.70	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	90.15	104.16	0.18	11.98	4.42	5.16	16.78	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	88.16	126.76	0.22	10.53	5.04	4.39	22.81	0.00	2.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	94.22	281.66	0.99	7.93	6.94	5.95	67.44	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	102.89	78.22	0.40	14.77	6.46	6.33	9.76	0.00	1.58
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	98.66	84.74	0.00	14.73	6.25	7.67	10.29	0.00	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	177.66	215.78	1.52	27.70	13.98	14.23	50.83	0.00	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	43.00	66.29	0.00	8.56	4.78	4.78	11.74	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	39.14	90.75	0.00	10.32	3.39	2.00	16.64	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.58	98.81	0.00	23.73	5.11	7.57	26.80	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	26.60	39.12	0.00	11.89	4.07	4.07	8.76	0.00	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	22.60	42.10	0.00	8.19	3.11	4.52	10.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	32.28	51.65	0.46	11.99	3.23	5.07	20.75	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	39.60	0.00	19.80	0.00	7.42	12.37	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	35.20	68.08	0.00	17.79	5.42	4.64	12.38	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	60.97	75.41	0.00	3.21	12.84	8.02	8.02	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	69.55	0.00	12.17	1.74	1.74	15.65	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.25	54.03	0.00	7.81	6.84	3.25	10.42	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	39.12	60.95	0.00	9.47	3.71	4.53	13.18	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	73.31	0.00	0.00	0.00	0.00	6.66	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.92	57.33	0.00	5.87	3.08	3.08	15.10	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.95	62.10	0.00	8.82	2.94	1.96	18.96	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	28.52	53.69	0.00	7.55	0.00	2.52	14.26	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	35.31	67.75	0.00	4.45	2.86	2.23	18.45	0.00	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	33.63	53.33	0.00	6.79	1.36	2.38	16.98	0.00	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	35.50	0.00	0.00	0.00	4.18	12.53	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	27.49	80.18	0.00	3.44	2.29	0.57	16.61	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	22.20	56.83	0.00	2.07	1.18	1.48	14.21	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	28.80	86.40	0.00	5.08	1.69	0.00	11.86	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	43.91	66.69	0.00	5.38	2.49	2.90	10.77	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.23	62.13	0.00	6.21	2.07	2.76	13.81	0.00	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	94.83	0.00	10.54	0.00	0.00	5.27	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	56.12	0.00	3.46	1.54	1.54	16.53	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	17.93	73.02	0.00	2.93	1.96	1.63	16.30	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	17.39	88.29	0.00	2.01	1.34	1.34	17.39	0.00	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	22.35	79.37	0.00	3.85	1.16	1.54	24.27	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.21	109.89	0.00	5.14	2.05	1.37	21.23	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	72.06	0.00	4.97	0.00	0.00	9.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	12.74	69.83	0.00	2.83	0.94	0.94	21.23	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.71	93.54	0.00	2.41	0.60	0.60	21.12	0.00	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	8.65	101.23	0.00	3.56	1.02	1.02	21.87	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.14	76.18	0.00	3.19	1.60	0.80	22.73	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	17.76	89.79	0.00	2.96	0.49	0.49	26.64	0.00	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	62.56	0.00	3.54	1.18	0.00	31.87	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.09	70.60	0.00	2.92	0.58	1.17	18.67	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	23.26	75.93	0.00	2.63	0.88	0.44	25.02	0.00	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.95	54.25	0.00	0.85	0.00	1.70	22.04	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.12	59.69	0.00	1.19	0.60	1.19	23.28	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	22.81	54.83	0.00	2.91	0.49	1.46	9.70	0.49	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	75.33	28.53	0.00	23.97	4.57	5.71	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	75.26	34.93	0.42	22.87	4.99	10.40	1.66	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	132.69	24.74	0.00	50.60	9.00	9.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	130.04	34.57	0.32	27.91	10.47	13.00	2.22	0.00	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	144.54	23.39	0.84	24.65	7.94	15.87	0.84	0.00	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	76.59	28.78	0.93	6.38	3.13	3.13	1.28	0.00	1.16
Hep-2 cells mock treated, biol_rep2	11899-125E9	79.84	28.87	0.68	6.75	2.03	2.70	3.21	0.34	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	66.66	22.98	1.37	5.69	2.96	2.28	2.73	0.00	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	78.37	29.29	1.20	7.76	3.39	3.61	1.64	0.00	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	69.42	33.53	1.72	7.52	3.01	2.15	2.79	0.00	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	69.54	28.42	1.51	4.52	1.94	2.58	0.86	0.00	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	75.72	29.02	0.75	5.48	4.23	3.24	1.37	0.12	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	76.68	27.28	1.20	4.80	2.23	1.89	2.74	0.00	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	73.04	21.46	0.32	4.16	2.88	1.28	2.24	0.00	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	86.74	61.56	0.00	10.63	8.95	5.04	1.68	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	138.49	51.50	0.00	16.45	12.12	11.25	3.03	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	150.70	79.31	0.00	13.22	7.93	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	87.12	50.79	0.35	13.05	6.35	4.59	2.82	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	77.74	47.95	0.00	7.99	5.09	5.81	2.18	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	174.49	56.65	0.17	19.93	12.06	8.22	3.50	0.00	2.10
Hepatocyte, donor1	11523-119I2	3.63	0.00	335.34	1.21	0.00	0.00	0.00	41.16	3.63
Hepatocyte, donor2	11603-120I1	10.77	7.54	124.97	2.15	0.00	1.08	0.00	24.78	2.15
Hepatocyte, donor3	11684-122I1	16.57	11.66	185.29	2.45	0.61	1.84	1.84	36.81	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.69	26.11	0.00	7.18	3.26	0.65	2.61	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	62.40	52.78	8.21	7.52	3.32	4.02	4.89	0.35	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	141.87	50.35	0.00	26.48	10.84	9.88	3.16	0.00	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	35.02	0.00	12.74	0.00	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	73.43	40.05	0.00	13.35	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	108.33	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	31.84	30.46	0.00	12.46	0.00	2.77	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	60.06	40.04	0.00	2.50	0.00	2.50	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	35.60	0.00	35.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	35.88	0.00	2.56	5.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	41.14	0.00	9.14	0.00	13.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	60.10	48.73	0.00	17.87	1.62	1.62	9.75	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	35.01	25.01	0.00	5.00	1.67	3.33	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	50.83	0.00	14.52	0.00	14.52	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	46.32	38.38	0.00	5.29	0.00	1.32	5.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	29.93	43.24	0.00	3.33	2.22	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	57.62	0.00	5.24	10.48	10.48	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	44.09	28.34	0.00	5.67	1.89	6.30	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	30.93	0.00	1.55	0.00	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	52.98	29.72	0.00	7.75	1.94	2.58	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	45.08	38.64	0.00	4.83	1.61	3.22	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	47.79	0.00	0.00	0.00	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	49.71	32.60	0.00	4.89	0.81	4.07	4.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	32.33	18.89	0.00	7.14	2.52	1.68	2.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	43.12	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	50.63	27.33	0.80	4.82	2.41	3.21	0.80	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	48.01	24.93	0.00	4.62	2.77	1.85	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	50.51	31.63	0.00	7.55	0.94	3.30	1.89	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	11.79	0.00	5.44	0.91	0.91	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	51.65	30.13	0.00	8.61	0.00	3.23	3.23	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	24.14	0.00	3.81	2.54	3.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.35	30.61	0.00	6.38	1.91	1.91	1.28	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	38.28	25.52	0.00	5.47	0.00	0.00	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	42.13	26.42	0.00	6.43	2.86	2.14	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	19.91	0.00	3.32	0.00	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	38.89	24.69	0.00	8.03	1.54	2.78	1.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	35.12	0.00	3.51	3.51	1.76	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	40.86	0.00	0.00	0.00	3.14	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	54.24	36.16	0.00	9.04	4.17	0.70	4.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	50.90	0.00	2.21	4.43	0.00	13.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	48.63	35.66	0.00	6.48	0.00	0.00	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	83.71	45.34	0.00	17.44	1.74	3.49	5.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	42.75	67.49	0.00	13.50	0.00	6.75	6.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	34.85	0.00	10.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	90.68	45.87	0.00	12.80	5.33	1.07	6.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	31.87	37.41	0.00	5.54	1.39	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	42.74	0.00	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	56.15	41.42	0.00	8.28	0.00	1.84	3.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	63.53	0.00	3.03	0.00	3.03	12.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	93.13	86.92	0.00	0.00	18.63	6.21	24.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	93.05	100.45	0.00	6.34	4.23	5.29	3.17	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	161.73	19.50	0.08	30.68	13.79	18.52	0.41	0.00	1.31
Keratinocyte - epidermal, donor2	11349-117G8	65.01	13.47	0.00	4.69	1.76	5.86	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	140.66	40.32	0.19	20.73	9.37	6.82	1.61	0.09	1.51
Keratinocyte - oral, donor1	11251-116E9	111.47	39.28	3.75	12.83	5.22	3.75	3.97	0.11	0.45
Keratocytes, donor1	11527-119I6	314.26	74.96	0.00	25.10	24.41	27.16	5.85	0.00	1.72
Keratocytes, donor2	11607-120I5	148.82	49.22	0.00	26.95	14.06	5.86	2.34	0.00	1.17
Keratocytes, donor3	11688-122I5	256.88	69.75	0.00	21.54	17.78	13.24	5.14	0.00	3.56
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	70.33	4.40	8.79	2.20	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	149.95	40.99	0.00	9.71	11.87	12.94	3.24	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	175.65	78.77	1.15	46.82	20.76	16.95	9.00	0.12	1.27
Lens Epithelial Cells, donor3	11690-122I7	306.26	95.76	0.00	57.42	27.45	40.67	6.05	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	93.79	20.75	0.00	18.26	11.50	7.94	1.07	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	68.93	19.26	0.28	13.40	11.16	8.09	1.67	0.00	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	85.79	22.98	0.31	14.48	13.38	5.67	1.89	0.00	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	65.60	19.36	0.54	7.53	10.22	5.38	0.54	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	71.86	19.54	0.00	14.50	10.09	7.56	1.26	0.00	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	64.69	14.45	0.00	12.72	10.46	5.93	0.43	0.00	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	87.00	18.06	0.00	11.49	11.90	5.75	1.64	0.00	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	58.40	14.66	0.00	10.62	10.37	4.80	1.01	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	75.16	18.44	0.00	14.08	10.84	7.32	0.70	0.00	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	75.15	17.40	0.00	15.03	8.31	9.10	2.37	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	78.14	16.48	0.19	17.84	11.83	6.01	1.16	0.00	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	50.73	10.55	0.00	9.07	6.48	4.26	1.30	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	74.56	25.78	0.00	15.68	9.76	5.57	1.74	0.00	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	78.00	21.23	0.00	14.55	11.45	5.72	1.19	0.00	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	67.16	17.17	0.00	12.91	10.30	2.75	0.82	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	85.30	16.32	0.00	18.48	9.55	10.16	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	55.80	12.78	0.00	10.91	7.79	3.43	1.25	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	72.10	21.04	0.00	10.25	8.23	6.04	0.91	0.00	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	72.08	19.42	0.33	8.56	9.22	5.59	0.66	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	52.42	16.11	0.29	12.01	8.49	4.98	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	61.98	14.94	0.00	3.98	6.22	4.23	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	85.35	26.19	0.97	11.64	7.27	9.21	1.45	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	79.71	23.16	0.00	14.54	12.39	6.19	1.89	0.00	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	81.14	17.71	0.00	9.23	8.78	5.30	1.21	0.00	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	63.25	21.25	0.00	8.29	9.33	5.18	1.04	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	87.11	21.15	0.42	15.49	12.98	11.31	1.47	0.00	2.09
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	74.43	16.84	0.15	12.03	8.72	5.11	1.80	0.15	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	82.55	17.88	0.00	15.13	10.32	6.19	0.00	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	90.69	18.63	0.00	16.18	15.80	8.47	0.75	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	64.15	13.15	0.00	10.82	10.18	3.92	1.27	0.00	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	81.41	22.29	0.00	17.44	12.60	7.27	0.48	0.00	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	103.87	13.56	0.00	19.85	11.25	12.24	1.98	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	61.57	16.85	0.00	11.03	9.29	4.58	0.87	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	89.22	19.62	0.00	17.77	13.70	7.77	1.85	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	74.87	17.05	0.00	13.34	12.85	5.93	0.49	0.00	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	65.31	13.89	0.00	11.69	9.49	6.05	0.14	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	85.23	22.51	0.00	16.73	13.51	9.01	1.29	0.00	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	92.52	24.04	0.61	19.78	16.74	9.74	1.83	0.00	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	84.96	17.22	0.00	12.04	11.62	6.44	0.70	0.00	1.54
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	90.31	19.56	0.00	19.20	11.02	7.11	1.78	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	73.20	16.97	0.00	14.54	10.18	4.85	0.97	0.00	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	52.91	12.76	0.00	11.20	9.34	2.96	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	75.20	23.63	0.00	12.89	12.89	5.73	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	98.33	13.39	0.00	18.95	16.01	9.47	0.65	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	56.50	9.89	0.00	9.89	6.12	3.77	0.47	0.00	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	114.97	16.95	0.12	25.49	19.18	11.01	0.99	0.00	1.86
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	82.22	14.60	0.00	14.86	15.37	6.40	0.51	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	54.90	13.43	0.30	7.76	7.76	4.48	1.49	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	9.06	2.27	2.27	0.00	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	35.29	23.01	0.77	3.07	2.30	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	10.39	0.74	2.97	0.00	2.97	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	25.81	10.58	0.85	4.65	1.27	1.69	1.69	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.02	11.96	0.70	1.41	1.41	2.81	2.11	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	25.22	14.01	0.93	0.93	0.93	0.00	0.93	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	25.76	10.31	1.03	3.61	1.55	0.52	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	33.30	15.46	1.19	0.00	1.19	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	29.41	8.82	2.94	2.49	0.45	0.68	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.37	17.45	2.62	3.49	0.87	1.45	1.16	0.00	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	47.72	24.76	1.35	1.80	0.90	2.70	1.35	0.00	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	36.58	13.28	1.35	5.15	1.63	1.63	1.63	0.27	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	35.43	13.35	1.54	2.05	1.03	1.54	1.54	0.51	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	36.34	23.64	2.47	2.82	1.41	2.47	1.06	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	30.65	15.99	1.33	2.67	2.67	1.33	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	35.15	14.77	1.53	4.08	1.53	1.53	1.02	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	45.62	22.41	2.13	3.74	0.80	2.67	2.13	0.80	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	42.51	20.22	2.08	4.53	2.08	2.08	1.32	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	30.06	14.73	1.23	0.61	1.84	3.07	2.45	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	49.74	26.91	0.82	3.26	0.82	2.45	2.45	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	48.94	18.53	2.50	5.21	1.67	2.08	1.87	0.00	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	42.88	19.06	1.40	5.61	1.40	2.24	1.68	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	35.03	18.55	0.00	3.09	0.00	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.00	21.19	0.87	4.64	2.90	2.03	2.03	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	39.16	21.82	0.90	5.98	2.39	2.99	1.49	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	44.26	24.34	1.11	3.87	0.55	2.77	3.32	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.89	20.15	2.47	3.89	1.06	1.06	1.41	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	43.15	14.38	0.00	3.32	1.11	1.84	2.58	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	34.54	17.27	0.00	3.45	1.15	0.00	0.00	0.00	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	37.22	19.57	1.92	1.54	2.30	2.30	1.15	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	30.00	12.45	1.13	6.23	0.57	1.70	2.26	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	38.56	10.67	0.00	4.10	1.64	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	36.15	14.46	2.26	2.26	1.36	1.36	1.36	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	35.19	14.36	0.72	7.18	4.31	3.59	2.87	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	42.57	25.39	1.49	2.99	0.00	2.24	1.49	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	36.79	18.58	0.37	4.83	1.49	1.11	1.11	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	40.92	12.49	0.43	3.88	1.72	1.29	1.29	0.00	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	47.10	8.56	0.00	2.57	0.86	0.86	0.86	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	43.31	16.99	0.33	3.66	1.00	1.33	2.67	0.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	39.22	13.88	0.60	3.02	0.60	0.60	0.00	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	39.10	9.95	0.00	2.13	1.42	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	37.47	18.90	0.69	2.75	0.69	1.72	1.72	0.00	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	38.11	10.20	1.61	3.22	3.22	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	37.03	16.83	0.67	2.69	0.00	1.35	2.02	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	52.60	19.63	0.74	5.93	0.74	1.85	2.22	0.37	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	43.03	9.30	1.16	2.33	1.16	3.49	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	9.52	1.06	3.17	1.06	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	36.41	17.21	2.00	4.00	2.40	0.40	2.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	25.44	17.44	1.45	2.18	1.45	0.73	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	35.26	17.63	1.53	3.07	1.53	3.07	3.07	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	40.45	13.32	1.48	1.97	1.97	1.97	1.48	0.00	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	24.46	12.23	0.94	3.76	0.00	1.88	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	31.68	13.58	0.00	3.02	0.50	1.01	2.01	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.25	14.87	1.35	4.06	0.90	0.90	1.35	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	18.93	0.00	1.72	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.06	17.37	0.89	0.45	1.34	1.78	1.34	0.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	37.54	18.77	1.96	1.56	1.56	1.96	1.17	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	19.13	0.66	2.64	1.32	1.32	1.98	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.58	17.12	1.56	1.56	0.52	4.15	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	41.13	22.75	0.00	3.06	1.31	1.31	1.31	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	40.81	17.89	0.00	6.15	1.68	2.80	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	36.21	26.94	0.00	2.21	1.77	1.32	2.21	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	39.73	18.51	2.31	1.16	1.54	1.54	1.54	0.77	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.01	17.72	1.01	6.08	2.03	0.00	2.03	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	46.62	20.67	1.44	4.33	0.96	2.40	1.92	0.96	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	44.92	19.08	0.40	4.37	1.99	1.59	1.99	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	42.53	20.66	0.00	7.29	1.82	1.22	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	38.04	15.22	1.38	0.69	1.38	2.77	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	51.30	23.94	1.14	6.46	2.66	0.76	1.52	0.38	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	35.63	19.62	2.58	4.13	1.55	1.55	2.58	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	50.19	12.09	0.60	0.60	3.63	1.81	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	45.95	21.23	1.27	4.44	0.95	2.54	0.32	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	39.45	17.59	1.07	3.20	0.53	2.67	0.53	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	51.72	21.84	1.15	0.00	1.15	0.57	1.15	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	36.51	14.40	3.09	1.54	1.03	4.11	2.06	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.17	18.39	0.71	9.20	1.41	4.24	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	51.07	15.89	1.13	1.70	1.13	2.27	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.02	19.14	2.08	3.74	1.25	2.50	2.91	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	39.94	18.79	1.57	6.26	0.00	2.35	3.13	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	51.36	16.70	0.84	1.25	0.84	1.25	1.67	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	41.82	19.51	4.18	2.32	1.39	1.86	1.39	0.00	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	47.50	28.10	1.34	0.67	1.34	0.67	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	62.55	21.39	2.14	1.60	3.21	2.14	1.07	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	57.38	25.86	0.40	6.06	4.85	1.62	2.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	48.64	20.19	0.92	6.42	0.92	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	77.35	10.67	0.89	0.00	0.89	4.45	0.89	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	64.40	30.20	2.28	6.27	1.71	0.00	0.57	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	50.62	20.71	0.00	4.60	2.30	3.83	0.77	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	59.64	19.15	1.09	3.28	1.09	2.19	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	63.70	21.83	0.89	4.01	3.12	2.67	2.23	0.00	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	41.07	14.04	1.04	6.76	2.34	2.60	1.04	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	61.01	13.93	0.00	1.33	4.64	3.32	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	66.52	10.39	0.00	12.47	0.00	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	74.53	51.05	15.95	11.85	9.34	5.47	2.51	0.23	0.68
Macrophage - monocyte derived, donor2	11313-117C8	109.74	29.18	1.84	25.69	13.21	8.44	0.92	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	122.56	55.45	1.97	28.31	9.70	6.42	2.75	0.00	1.57
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	121.60	18.05	0.00	25.49	12.21	20.71	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	188.24	19.81	0.16	37.55	12.68	29.47	0.32	0.00	1.11
Mallassez-derived cells, donor3	11930-125I4	143.02	21.54	0.14	25.30	13.48	19.18	0.83	0.00	0.56
Mammary Epithelial Cell, donor1	11273-116H4	155.44	19.73	3.59	22.72	10.36	9.57	1.10	0.20	1.10
Mammary Epithelial Cell, donor2	11350-117G9	154.33	24.90	2.61	17.95	7.82	8.40	2.03	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	102.51	25.94	0.00	16.71	7.73	5.24	0.75	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	48.81	23.73	8.14	8.14	4.07	5.42	2.03	0.00	0.00
Mast cell, donor1	11563-120D6	107.38	50.50	13.73	18.71	11.14	6.27	4.33	0.00	0.32
Mast cell, donor2	11565-120D8	152.45	98.36	9.81	49.93	27.04	14.26	10.40	0.00	0.59
Mast cell, donor3	11566-120D9	129.67	111.66	13.73	59.21	25.89	15.98	10.36	0.90	0.45
Mast cell, donor4	11567-120E1	138.82	97.69	9.04	54.25	28.90	13.12	10.11	0.35	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	96.37	34.27	16.19	21.07	13.09	9.98	3.44	0.44	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	77.63	11.09	5.25	33.85	8.17	14.01	2.92	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	67.11	54.84	18.70	13.54	8.72	3.79	5.28	0.34	0.57
Mast cell, expanded, donor8	11941-126A6	72.30	25.94	20.42	19.58	15.23	6.19	1.67	0.33	0.33
Melanocyte - dark, donor1	11502-119F8	85.97	20.40	0.30	16.22	13.33	3.48	1.39	0.00	0.30
Melanocyte - dark, donor2	11582-120F7	90.67	36.34	0.00	13.50	5.88	2.77	1.73	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	41.44	86.71	1.52	3.98	1.59	2.75	8.19	0.07	0.43
Melanocyte - light, donor1	11274-116H5	54.07	47.01	0.00	7.05	4.70	3.06	3.06	0.00	0.24
Melanocyte - light, donor2	11351-117H1	25.93	36.17	0.00	3.41	0.68	0.68	2.73	0.00	0.68
Melanocyte - light, donor3	11423-118G1	63.31	48.56	0.00	11.27	0.87	1.73	3.47	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	46.96	103.71	1.25	3.85	2.19	2.60	9.27	0.10	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	37.11	87.41	2.15	2.96	1.34	1.88	11.56	0.00	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	13.39	120.53	5.89	0.80	0.27	2.14	14.73	0.00	0.80
Meningeal Cells, donor1	11493-119E8	197.13	59.30	0.00	28.78	15.01	18.98	2.85	0.00	0.87
Meningeal Cells, donor2	11573-120E7	130.28	86.71	0.00	28.61	6.16	15.85	6.16	0.00	1.32
Meningeal Cells, donor3	11654-122E7	173.76	50.61	0.00	54.69	20.05	20.62	3.59	0.00	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	116.06	55.04	0.00	21.96	11.41	5.70	2.85	0.00	2.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	152.16	36.43	0.00	24.35	16.50	20.63	3.12	0.00	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	63.08	14.46	0.00	7.88	7.88	2.63	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	77.18	20.93	0.00	10.47	2.62	6.54	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	128.45	30.86	0.00	25.12	10.05	12.20	2.87	0.00	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	193.34	51.04	0.00	21.81	11.65	11.65	3.60	0.00	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	127.67	55.29	1.01	16.59	10.05	13.07	2.01	0.50	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	132.07	50.54	0.00	19.12	9.89	6.81	2.64	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	130.78	63.56	0.00	24.11	10.96	6.58	4.38	0.00	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	133.81	58.72	0.00	24.35	12.07	10.43	1.84	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	192.25	51.39	0.14	17.31	9.83	9.70	2.22	0.00	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	102.22	47.21	0.00	14.50	5.20	7.81	5.95	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	285.91	57.10	0.53	35.79	24.21	16.05	6.71	0.00	3.03
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	73.89	36.20	0.00	6.23	3.26	2.97	5.04	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	51.38	18.68	0.00	0.00	9.34	2.34	4.67	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	83.89	46.75	0.00	13.45	6.40	3.20	2.56	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	107.75	19.49	0.00	19.14	17.37	14.53	1.42	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	219.53	57.54	0.31	21.58	15.01	12.51	5.94	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	83.45	53.70	0.00	10.89	9.43	5.08	3.63	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	229.11	48.53	0.80	49.06	17.77	25.46	2.65	0.00	1.59
Mesothelial Cells, donor2	12156-128G5	188.18	43.04	1.00	54.55	17.52	32.03	2.00	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	226.19	70.02	0.14	49.72	15.46	20.38	4.05	0.00	2.67
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	162.04	37.81	0.00	81.02	22.96	22.96	8.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	164.27	65.51	12.56	18.96	11.08	5.66	3.20	0.00	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	157.54	32.39	7.36	36.81	14.13	13.25	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	107.17	41.48	0.00	34.57	10.37	27.66	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	86.17	44.63	12.09	9.92	6.20	4.65	2.17	0.31	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	112.64	30.91	7.26	26.14	11.82	8.30	2.70	0.00	2.07
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	94.96	23.16	4.63	25.48	20.84	11.58	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	138.65	54.56	11.51	15.02	11.76	7.26	4.75	0.00	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	161.52	45.15	4.19	42.36	20.02	16.76	3.26	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	19.47	0.00	97.33	0.00	58.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	125.79	56.90	9.35	15.44	11.99	6.10	3.45	0.20	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	154.82	30.49	2.38	34.84	14.65	9.50	2.38	0.00	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	25.65	0.00	17.10	0.00	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	102.65	38.94	7.08	9.73	2.65	2.65	4.42	0.00	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	129.56	31.91	11.40	28.88	12.92	9.12	1.52	0.00	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	88.17	19.74	1.32	42.11	19.74	13.16	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	92.95	49.24	9.97	11.46	7.85	5.73	3.61	0.21	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	127.07	32.23	1.84	34.99	16.57	6.45	2.76	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	123.69	56.63	4.17	18.18	9.54	5.96	5.66	0.00	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	114.01	25.15	0.00	48.62	16.77	25.15	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	33.95	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	109.64	52.19	12.55	10.29	10.29	5.52	3.51	0.00	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	133.57	35.17	4.75	26.86	13.78	9.27	2.38	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	75.19	19.90	1.66	24.88	7.19	8.85	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	103.15	51.81	10.82	10.59	7.37	5.76	2.07	0.00	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	119.89	26.29	7.15	22.72	9.04	9.25	3.16	0.00	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	122.91	47.70	6.11	17.53	9.58	5.71	3.06	0.00	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	96.76	48.27	18.24	11.16	6.65	4.29	1.93	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	117.81	38.46	4.67	27.34	15.56	9.56	2.22	0.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	20.64	0.00	61.91	20.64	20.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	97.68	51.03	6.79	12.26	6.57	4.60	1.97	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	111.53	39.54	2.53	40.05	13.18	10.14	1.01	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	76.22	18.23	0.00	29.83	8.28	8.28	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	126.93	53.81	10.06	19.03	9.51	5.44	3.81	0.82	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	131.75	37.94	4.71	32.35	15.00	11.47	2.35	0.00	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	94.86	30.53	0.00	25.08	19.63	11.99	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	93.23	42.29	9.61	11.05	6.25	4.81	2.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	116.47	26.01	5.60	29.22	13.61	8.40	1.20	0.00	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	117.92	61.70	1.37	30.17	15.08	10.97	4.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	131.65	57.57	6.51	14.52	9.51	6.01	4.51	0.00	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	26.95	53.89	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	91.73	69.31	0.00	26.50	2.04	2.04	8.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	133.57	47.30	2.63	13.14	11.39	6.57	2.19	0.00	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	115.88	20.97	0.00	43.04	13.24	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	119.11	56.99	0.64	27.54	17.29	10.89	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	118.75	38.43	7.19	14.88	10.16	7.69	1.74	0.00	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	97.43	20.18	0.70	27.84	9.05	8.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	79.56	46.41	0.00	28.73	11.05	13.26	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	123.08	36.92	3.76	11.97	9.23	6.84	2.05	0.00	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	116.41	28.01	1.31	30.20	11.82	4.38	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	143.46	53.26	0.71	33.02	18.11	13.49	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	113.90	35.07	3.09	14.59	9.82	9.26	1.40	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	104.74	17.87	0.83	17.87	12.47	6.65	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	122.96	48.95	0.00	56.53	12.24	13.99	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	152.34	41.33	0.90	25.34	11.16	9.05	1.21	0.00	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	92.66	23.79	2.50	19.20	6.26	10.02	0.83	0.00	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	137.16	72.19	0.00	28.88	28.88	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	149.62	37.87	0.92	16.62	14.78	9.24	1.85	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	127.48	34.15	2.28	30.73	19.35	10.24	1.14	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	178.94	43.67	0.55	31.92	19.07	12.99	2.76	0.00	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	108.06	31.62	1.55	20.47	13.73	6.22	2.33	0.00	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	112.39	43.33	0.00	22.74	11.58	12.01	3.00	0.00	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	120.05	53.36	0.00	39.38	19.69	12.07	3.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	129.71	45.64	0.27	25.89	11.21	8.54	1.60	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	135.90	36.82	2.10	23.65	12.87	9.28	1.80	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	144.50	40.82	0.00	24.01	11.87	9.46	3.39	0.00	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	111.48	43.00	0.64	12.10	8.92	5.41	2.23	0.00	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	116.09	31.62	3.32	28.75	15.04	12.16	1.55	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	137.27	46.64	0.00	39.06	18.20	11.76	3.41	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	113.36	39.77	0.57	17.05	8.52	7.10	1.99	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	122.66	34.66	1.97	18.44	11.55	8.36	2.46	0.00	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	114.69	63.86	0.00	31.93	15.64	11.73	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	134.66	54.98	0.59	17.05	12.35	8.82	2.35	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	138.40	40.94	2.02	24.22	11.82	10.67	2.31	0.00	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	161.56	39.57	0.82	54.40	17.31	15.66	4.95	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	118.82	43.18	0.60	18.46	8.93	8.34	2.38	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	26.37	15.07	0.00	0.00	7.53	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	40.99	21.39	7.13	5.35	3.56	0.00	0.00	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	68.34	85.43	22.67	8.54	5.59	1.97	8.87	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	54.70	58.91	9.47	5.26	4.21	2.10	3.16	0.00	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	53.97	34.79	19.57	10.28	4.55	3.56	2.57	0.59	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	125.73	82.89	10.24	11.18	5.59	6.52	5.59	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	75.48	62.71	21.78	6.01	3.00	4.51	5.63	0.38	2.25
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	95.88	48.47	6.13	13.85	7.72	6.66	4.26	0.00	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	42.64	42.98	11.99	5.99	2.26	2.04	2.38	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	61.88	53.78	8.10	7.37	2.95	2.95	2.95	0.00	3.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	60.83	71.45	20.52	4.76	4.40	2.20	2.56	1.10	2.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	101.11	46.67	7.78	14.00	4.67	4.67	3.11	0.00	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	82.30	65.20	25.12	6.95	3.21	2.14	5.88	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	61.82	61.82	15.46	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	49.49	87.86	8.08	3.03	3.03	3.03	4.04	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	80.11	57.76	2.95	12.65	6.75	3.37	3.37	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	84.44	43.58	24.51	2.72	4.09	2.72	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	80.11	37.51	24.16	4.45	3.18	3.81	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	57.50	43.73	37.25	7.29	6.48	4.86	4.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	66.46	46.82	13.59	12.08	3.02	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	39.97	0.00	17.13	0.00	5.71	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	32.62	9.79	22.84	13.05	26.10	9.79	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	114.06	4.75	0.00	14.26	9.50	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	87.84	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	311.52	56.23	0.00	35.76	23.27	35.12	2.59	0.00	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	226.81	81.00	0.00	20.90	13.59	11.50	2.61	0.00	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	145.51	40.72	0.00	40.72	10.68	20.69	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	177.38	50.92	0.42	44.66	17.11	22.54	1.67	0.00	2.92
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	215.62	58.18	0.38	36.51	15.78	17.49	2.85	0.00	3.04
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	124.48	81.39	0.00	33.51	11.17	12.77	3.19	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	93.15	37.40	0.00	23.12	7.48	10.88	0.00	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	582.53	44.10	3.68	95.56	53.29	51.45	7.35	0.00	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	75.34	28.04	0.00	16.32	7.95	9.21	1.67	0.00	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	142.48	37.42	0.70	29.98	11.62	14.64	0.93	0.00	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	85.39	40.26	0.27	22.43	7.03	10.81	2.43	0.00	1.89
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	131.61	59.92	1.05	23.34	8.62	10.93	2.73	0.42	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	846.24	144.75	0.00	55.67	77.94	44.54	0.00	0.00	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	121.11	36.73	0.99	33.75	13.40	16.38	2.98	0.00	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	82.28	43.85	0.00	12.99	4.33	7.04	4.60	0.00	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	105.63	35.59	0.45	24.48	9.52	11.11	2.04	0.00	3.40
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	82.63	55.85	0.65	13.72	4.74	6.04	3.10	0.00	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	96.05	62.70	0.91	12.76	6.93	10.02	4.56	0.00	2.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	101.84	53.57	0.53	16.97	10.08	8.49	1.06	0.00	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	105.05	55.23	0.60	26.41	7.20	12.01	1.80	0.00	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	174.26	72.53	0.98	17.39	8.20	8.86	7.55	0.00	5.25
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	102.78	53.50	0.00	19.68	10.25	9.92	1.46	0.00	3.25
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	115.88	85.37	0.71	18.87	7.41	10.23	6.00	0.00	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	94.94	56.96	0.00	12.66	6.33	12.66	3.52	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	95.62	51.49	0.00	21.15	10.11	6.90	3.68	0.00	3.68
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	66.20	53.34	0.32	12.85	5.14	3.86	2.25	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	301.43	86.22	1.38	26.56	8.28	14.49	3.45	0.00	11.73
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	783.82	219.97	2.53	65.74	32.87	53.10	7.59	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	119.64	79.98	0.67	13.81	7.57	10.03	4.68	0.22	1.78
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	89.34	47.42	0.42	8.47	7.62	8.89	3.81	0.00	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	112.03	63.14	0.00	15.90	5.70	7.83	4.51	0.00	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	97.01	54.51	0.00	12.02	6.44	6.01	2.15	0.00	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	803.47	216.67	0.00	126.39	54.17	18.06	9.03	0.00	54.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	109.30	68.64	0.00	11.66	8.66	9.66	5.00	0.00	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	133.00	67.18	0.45	10.82	9.02	14.43	5.41	0.00	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	101.18	36.11	0.00	13.09	11.90	12.70	1.98	0.00	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	90.08	38.07	0.00	15.79	4.64	8.36	1.86	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	98.38	50.70	0.38	8.32	5.68	6.05	3.03	0.00	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	161.64	57.03	0.00	25.09	12.06	12.06	3.58	0.00	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	113.30	84.98	0.44	12.64	6.97	6.97	6.97	0.00	2.18
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	124.38	82.32	0.00	16.28	5.88	12.21	7.69	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	94.36	44.10	0.00	14.11	8.82	14.99	1.76	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	83.11	45.21	0.00	10.64	5.98	4.65	2.66	0.00	5.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	107.15	62.50	0.50	10.91	9.92	5.95	6.45	0.00	2.48
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	139.35	62.40	0.00	18.76	11.48	11.87	3.83	0.00	3.45
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	149.11	114.32	0.00	10.59	7.26	5.14	3.63	0.00	2.12
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	141.68	69.18	0.22	17.02	11.05	10.39	5.08	0.00	2.43
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	105.04	39.30	0.68	12.88	8.13	8.81	0.68	0.00	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	643.80	112.41	10.22	45.99	40.88	30.66	15.33	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	89.62	65.24	0.61	11.58	2.44	7.32	2.44	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	129.67	50.36	0.00	15.74	9.13	7.87	3.46	0.00	4.41
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	108.65	93.82	0.91	8.47	7.26	6.36	7.26	0.00	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	85.44	47.47	0.00	6.33	8.70	11.87	5.54	0.00	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	368.43	98.63	2.27	31.74	15.87	18.14	3.40	0.00	12.47
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	409.69	75.87	30.35	20.23	15.17	30.35	5.06	0.00	25.29
Myoblast, donor1	11241-116D8	187.83	27.95	0.37	57.39	25.72	43.73	1.49	0.00	3.85
Myoblast, donor2	11322-117D8	183.35	48.91	0.38	37.02	18.03	15.53	3.07	0.00	3.26
Myoblast, donor3	11398-118D3	232.06	41.03	0.50	62.72	26.07	32.79	2.35	0.00	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	36.78	24.22	0.88	18.24	3.06	7.00	3.94	0.15	0.88
Natural Killer Cells, donor1	11230-116C6	36.59	13.22	18.14	15.99	4.31	5.84	0.92	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	43.12	7.24	7.24	23.22	2.71	4.82	2.41	0.30	0.60
Natural Killer Cells, donor3	11387-118C1	42.88	15.09	9.75	15.64	3.31	4.23	1.47	0.00	0.18
Neural stem cells, donor1	11275-116H6	170.94	119.77	2.90	52.99	29.76	27.95	14.88	0.00	1.09
Neural stem cells, donor2	11352-117H2	186.79	179.08	1.93	17.33	13.48	11.55	15.41	0.00	0.00
Neurons, donor1	11494-119E9	151.34	111.51	1.14	14.79	12.52	10.24	14.79	0.00	2.28
Neurons, donor2	11574-120E8	157.20	88.29	0.66	21.36	12.99	6.60	18.71	0.00	1.10
Neurons, donor3	11655-122E8	100.30	100.30	0.00	9.87	8.22	3.29	12.33	0.00	5.76
Neutrophils, donor1	11233-116C9	103.01	77.02	3.71	16.70	13.92	6.50	7.42	0.00	0.93
Neutrophils, donor2	11314-117C9	153.64	60.88	2.90	26.09	8.70	5.80	2.90	0.00	8.70
Neutrophils, donor3	11390-118C4	180.81	175.92	0.61	26.27	23.21	17.71	14.05	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	100.09	82.28	0.36	13.06	5.11	4.75	5.70	0.00	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	119.17	80.10	0.00	16.93	5.54	3.26	5.21	0.00	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	200.95	79.22	0.00	16.85	15.24	10.63	2.81	0.00	2.01
Olfactory epithelial cells, donor1	11933-125I7	142.88	81.49	0.00	8.81	3.72	5.92	4.68	0.00	4.40
Olfactory epithelial cells, donor2	11934-125I8	212.63	64.56	0.58	18.09	7.82	12.88	4.78	0.00	7.67
Olfactory epithelial cells, donor3	11935-125I9	201.58	85.36	0.34	16.34	9.65	9.53	5.11	0.11	4.31
Olfactory epithelial cells, donor4	11936-126A1	205.02	118.73	0.29	16.27	9.16	7.50	6.92	0.10	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	170.31	56.57	0.00	19.86	10.23	4.21	3.01	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	214.18	34.46	0.21	31.05	18.93	30.63	2.77	0.00	0.85
Osteoblast - differentiated, donor2	11353-117H3	149.75	43.44	0.00	25.15	11.43	14.86	5.72	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	162.63	30.41	0.00	19.24	14.28	13.03	3.10	0.00	3.10
Osteoblast, donor1	11277-116H8	78.96	25.99	0.00	11.14	6.45	6.45	0.98	0.00	0.59
Osteoblast, donor2	11354-117H4	188.22	47.06	0.00	25.99	11.24	11.94	2.81	0.00	2.81
Osteoblast, donor3	11426-118G4	180.40	58.30	0.00	31.64	9.95	9.60	3.55	0.00	2.84
Pancreatic stromal cells, donor1	11249-116E7	190.04	27.04	0.93	43.38	17.52	23.00	2.11	0.00	0.93
Pericytes, donor1	11491-119E6	83.12	35.27	0.11	8.90	5.23	6.68	3.45	0.00	0.89
Pericytes, donor2	11571-120E5	97.11	59.31	0.00	10.19	4.75	10.19	4.07	0.00	0.91
Pericytes, donor3	11652-122E5	203.45	55.13	0.00	31.13	15.26	17.29	3.87	0.00	3.87
Perineurial Cells, donor1	11499-119F5	161.96	39.67	0.00	34.25	12.55	14.58	3.16	0.00	0.45
Perineurial Cells, donor2	11579-120F4	123.11	32.20	0.18	18.49	11.59	6.72	3.04	0.00	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	71.40	32.19	7.33	13.07	6.37	7.97	3.51	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	52.16	25.47	4.65	10.28	3.18	3.43	1.47	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	51.38	29.51	4.01	13.20	4.40	4.14	1.68	0.13	0.39
Placental Epithelial Cells, donor1	11278-116H9	64.81	7.41	0.24	5.74	7.41	3.35	0.24	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	139.72	12.20	0.00	6.65	5.54	5.54	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	93.65	23.36	0.20	8.25	2.94	2.94	1.18	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	175.31	22.47	0.32	35.13	15.19	18.35	1.58	0.00	5.70
Preadipocyte - breast, donor1	11467-119B9	250.05	13.69	0.00	58.34	29.45	37.33	1.69	0.00	2.44
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	254.40	32.63	0.26	23.89	13.05	22.58	2.09	0.00	2.35
Preadipocyte - breast, donor2	11328-117E5	231.45	26.12	0.23	46.61	16.44	22.74	0.90	0.00	2.25
Preadipocyte - omental, donor1	11468-119C1	362.30	29.73	0.43	73.42	39.53	53.60	1.39	0.00	2.24
Preadipocyte - omental, donor2	11329-117E6	267.56	33.17	0.87	46.70	21.39	25.32	2.18	0.00	1.31
Preadipocyte - omental, donor3	11403-118D8	258.42	46.84	0.72	56.87	18.34	23.92	2.29	0.14	3.87
Preadipocyte - perirenal, donor1	11469-119C2	247.05	23.62	0.00	20.67	12.80	10.83	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	64.19	8.29	0.00	23.96	5.22	13.82	0.61	0.00	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	146.27	29.22	0.18	43.74	15.58	15.41	1.77	0.00	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	137.93	20.43	0.00	43.59	12.26	13.79	0.51	0.00	0.68
Preadipocyte - visceral, donor1	11280-116I2	177.07	22.54	0.65	63.81	21.61	27.39	1.49	0.09	0.84
Preadipocyte - visceral, donor2	11357-117H7	206.62	34.51	0.00	58.44	18.87	21.63	1.38	0.00	1.84
Preadipocyte - visceral, donor3	11429-118G7	143.57	21.42	0.73	35.53	11.70	12.96	0.63	0.00	1.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	70.45	68.94	0.75	11.31	6.03	4.53	8.60	0.15	0.45
Prostate Epithelial Cells, donor2	11331-117E8	164.26	25.46	1.08	46.18	23.56	30.06	1.08	0.00	2.17
Prostate Epithelial Cells, donor3	11404-118D9	148.62	29.15	1.47	11.21	8.76	3.43	1.78	0.06	1.04
Prostate Stromal Cells, donor1	11254-116F3	204.91	51.94	0.00	36.22	17.43	17.54	4.44	0.00	0.80
Prostate Stromal Cells, donor2	11332-117E9	271.10	74.23	0.00	49.13	21.34	26.89	4.30	0.18	2.69
Prostate Stromal Cells, donor3	11405-118E1	231.60	67.88	0.10	52.14	19.60	21.79	3.34	0.00	2.40
Renal Cortical Epithelial Cells, donor1	11516-119H4	161.69	45.26	0.36	16.79	5.84	6.57	2.55	0.00	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	179.45	38.95	0.35	24.05	15.94	11.71	1.73	0.00	0.97
Renal Epithelial Cells, donor1	11517-119H5	72.53	22.32	0.00	6.09	3.55	3.04	1.52	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	92.47	41.26	0.00	11.38	6.40	6.40	3.56	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	140.27	31.87	0.00	24.56	11.54	11.43	2.33	0.00	1.59
Renal Glomerular Endothelial Cells, donor1	11514-119H2	103.49	36.09	0.00	14.98	12.94	2.72	2.04	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	170.88	49.73	0.00	13.21	18.19	10.24	1.48	0.00	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	162.07	95.02	0.00	17.76	12.65	6.22	4.44	0.00	4.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	50.57	31.28	0.00	6.65	8.65	2.00	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	118.41	43.80	0.00	13.65	6.38	6.82	2.64	0.00	1.10
Renal Mesangial Cells, donor2	11598-120H5	114.74	73.36	0.63	14.42	6.27	3.13	4.39	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	77.95	33.29	0.00	12.76	6.10	3.33	1.94	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	194.34	49.66	0.00	30.06	16.11	11.81	2.95	0.00	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	118.92	39.64	0.00	16.87	8.86	5.90	1.27	0.00	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	113.97	54.00	0.00	18.90	12.34	8.29	3.66	0.00	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	71.04	59.38	1.56	13.48	4.67	2.33	7.26	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	96.36	62.82	0.00	13.93	3.98	4.55	8.53	0.00	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	49.40	46.31	0.00	7.20	6.17	2.06	6.17	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	146.03	63.98	0.75	22.08	12.80	7.53	7.78	0.00	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	59.60	33.81	200.85	9.76	8.55	4.94	4.41	28.20	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	54.50	39.31	0.00	9.83	4.47	0.89	2.68	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	72.65	35.77	0.55	6.05	3.30	2.75	6.05	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	99.19	36.54	0.00	4.64	4.06	1.16	4.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	89.98	48.37	0.13	8.32	3.77	3.77	4.68	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	81.63	60.58	0.10	10.43	4.77	3.18	7.65	0.00	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	80.98	44.95	0.00	12.60	5.24	3.90	5.80	0.11	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	112.76	46.14	0.37	9.30	5.33	3.60	5.46	0.00	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	78.43	59.44	0.12	11.54	4.43	3.50	6.29	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	99.62	64.95	0.23	11.79	6.24	2.77	7.63	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	105.56	69.28	0.41	6.43	4.38	2.05	6.98	0.00	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	85.47	62.32	0.15	13.01	5.75	3.63	6.81	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	76.87	42.65	0.36	12.90	3.23	2.51	4.30	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	97.98	64.41	0.29	4.45	3.87	3.73	4.73	0.00	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	90.47	59.88	0.21	10.95	4.40	3.00	6.55	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	80.54	56.42	0.00	10.40	3.32	1.99	4.65	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	105.53	88.13	0.00	3.63	2.68	2.87	5.54	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	91.30	64.28	0.28	11.92	4.47	3.73	6.34	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	97.71	47.54	0.00	13.72	5.26	4.51	6.95	0.00	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	130.85	91.04	0.00	5.84	4.91	2.39	6.90	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	85.08	66.87	0.29	13.04	4.38	4.19	6.81	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	90.13	52.70	0.19	11.27	3.06	3.06	4.77	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	117.37	71.44	0.00	5.23	4.59	4.38	6.30	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	86.05	70.36	0.00	10.09	3.08	2.24	6.45	0.00	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	87.16	60.16	0.34	12.30	3.42	3.08	6.67	0.00	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	114.50	73.66	0.36	6.56	5.11	4.19	6.02	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	83.51	60.09	0.25	9.93	4.66	2.58	5.52	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	83.14	58.29	0.00	10.48	3.49	3.36	7.79	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	114.16	65.10	0.00	5.66	4.72	4.72	3.30	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	87.10	63.49	0.00	13.29	4.17	3.77	5.56	0.00	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	97.75	58.70	0.70	15.67	3.74	3.98	2.34	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	94.55	62.00	0.21	4.15	3.11	4.35	4.15	0.00	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	100.43	59.95	0.44	11.06	4.65	4.42	7.52	0.00	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	88.36	52.22	0.21	10.03	3.55	2.30	7.10	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	114.80	66.22	0.27	7.54	3.36	3.63	5.52	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	94.68	76.12	0.34	12.94	4.77	4.94	7.15	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	88.11	55.52	0.00	16.00	4.63	3.08	5.98	0.00	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	114.51	66.02	0.00	6.36	4.30	5.67	5.50	0.00	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	100.54	68.17	0.41	17.15	5.49	5.35	6.86	0.00	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	99.98	51.88	0.66	16.91	6.24	5.09	5.25	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	109.59	81.30	0.00	5.62	4.09	3.58	4.94	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	89.66	51.49	0.30	12.58	3.99	3.40	6.21	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	93.56	62.11	0.00	14.39	4.26	4.00	11.20	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	95.13	74.94	0.00	5.25	2.63	3.46	7.05	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	73.57	57.86	0.24	11.19	4.76	2.62	6.67	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	106.41	98.15	0.40	11.49	5.84	3.83	11.49	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	97.47	56.98	0.19	4.33	4.05	2.73	4.99	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	109.70	63.23	0.00	9.78	6.29	3.49	10.48	0.00	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	78.58	56.21	0.30	11.79	2.72	3.02	9.37	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	119.33	55.56	0.37	5.87	4.53	5.02	6.12	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	130.85	57.49	2.18	18.92	8.59	7.13	9.17	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	105.87	66.32	0.61	15.21	4.87	3.04	12.78	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	100.37	50.03	0.30	5.73	7.53	4.52	3.01	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	157.88	91.61	0.90	20.36	9.73	9.73	13.35	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	127.30	83.57	0.30	8.09	5.69	4.19	8.99	0.00	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	138.74	61.40	0.94	6.73	9.56	6.61	5.31	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	111.20	79.40	0.43	16.65	9.18	6.62	9.82	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	105.17	76.32	0.60	14.42	1.80	5.41	13.22	0.00	1.80
Schwann Cells, donor1	11498-119F4	76.73	41.75	0.00	9.78	4.14	5.27	1.88	0.00	0.38
Schwann Cells, donor2	11578-120F3	142.90	61.24	0.00	6.80	10.21	20.41	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	127.51	64.85	0.00	24.76	5.92	10.73	3.51	0.00	1.75
Sebocyte, donor1	11220-116B5	175.29	24.10	0.00	27.39	13.69	15.34	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	129.13	27.11	0.00	26.65	11.03	6.43	1.38	0.00	0.46
Sebocyte, donor3	11378-118B1	139.54	44.52	0.21	24.12	6.60	3.09	2.27	0.00	0.82
Sertoli Cells, donor1	11255-116F4	293.22	39.76	0.00	43.07	26.51	33.13	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	313.50	48.01	0.00	73.43	16.95	25.42	5.65	0.00	8.47
Skeletal Muscle Cells, donor1	11281-116I3	133.90	40.73	0.09	20.67	15.22	16.19	3.96	0.00	0.62
Skeletal Muscle Cells, donor2	11358-117H8	95.42	34.70	0.00	18.79	9.40	10.12	3.61	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	91.13	40.97	0.00	15.05	6.69	5.85	2.51	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	139.34	53.25	0.16	24.66	11.15	8.64	1.89	0.00	1.26
Skeletal Muscle Cells, donor5	11455-119A6	136.16	49.80	0.15	22.00	9.51	8.92	1.34	0.15	0.89
Skeletal Muscle Cells, donor6	11459-119B1	167.29	54.02	0.00	26.93	16.31	12.16	2.15	0.00	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	100.05	43.35	0.25	24.19	8.69	7.43	2.52	0.00	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	105.02	54.65	0.43	23.97	7.13	6.14	3.57	0.00	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	148.62	64.68	0.10	37.40	12.60	12.30	4.37	0.00	1.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	146.77	48.87	6.49	20.98	11.71	19.71	5.98	1.26	1.43
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	104.22	32.57	0.00	18.09	7.96	5.79	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	81.73	26.14	0.14	17.34	6.88	6.33	0.96	0.00	0.41
Skin - palm, donor1	10286-104F7	150.42	21.49	18.80	32.23	13.43	13.43	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	105.38	29.55	0.14	14.99	6.92	7.21	1.73	0.00	2.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	124.32	58.89	0.00	4.91	0.82	8.18	2.45	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	101.91	23.11	0.39	16.36	8.83	6.75	0.65	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	121.08	15.85	0.14	27.52	12.23	14.73	0.83	0.00	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	132.78	37.84	0.14	30.10	14.07	15.61	1.69	0.00	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	165.35	35.95	0.63	30.03	16.07	12.69	2.11	0.00	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	191.20	40.02	0.22	31.85	15.74	11.32	2.10	0.00	2.10
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	103.38	8.33	0.00	12.65	8.33	8.33	0.00	0.00	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	860.87	92.71	0.00	33.57	41.13	81.15	2.45	0.00	4.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	146.37	20.57	0.00	30.57	16.46	13.52	1.18	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	139.00	23.43	0.22	22.98	18.78	12.38	1.77	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	139.40	16.14	0.39	32.68	13.39	20.87	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	146.79	19.31	0.00	48.67	13.91	21.63	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	129.10	59.04	1.00	16.01	8.01	8.01	7.01	0.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	173.00	24.09	0.00	41.92	20.76	26.08	0.93	0.00	1.20
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	169.34	42.11	0.66	35.69	16.40	12.19	1.77	0.00	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	146.85	33.93	0.00	30.34	11.65	18.82	2.30	0.00	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	82.37	51.12	0.00	28.33	11.72	14.33	2.93	0.00	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	133.49	58.18	0.30	40.75	12.70	18.90	4.13	0.00	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	141.65	70.47	0.14	32.60	10.53	15.66	5.98	0.00	1.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	197.49	34.81	0.00	33.02	13.50	17.08	2.11	0.00	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	335.18	120.25	0.00	27.09	25.27	17.96	7.92	0.00	3.96
Smooth Muscle Cells - Carotid, donor1	11285-116I7	125.27	17.68	0.25	31.82	13.89	12.63	1.52	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	122.41	42.84	0.00	30.60	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	120.16	20.50	0.00	19.55	11.44	10.49	0.95	0.00	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	103.67	49.99	0.00	18.14	10.91	7.52	2.95	0.00	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	117.95	61.13	0.22	15.28	6.03	7.53	4.30	0.00	3.44
Smooth Muscle Cells - Colonic, donor3	11396-118D1	118.29	65.39	0.21	25.71	10.92	7.03	3.99	0.00	1.68
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	140.76	20.26	0.00	33.10	18.41	24.44	0.62	0.00	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	142.28	28.02	0.00	35.57	20.48	11.86	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	153.01	21.22	0.00	28.39	16.74	12.55	0.60	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	102.08	43.36	0.00	11.61	7.51	4.10	3.41	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	143.47	51.99	0.08	15.78	11.78	6.36	5.73	0.00	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	354.96	68.23	0.40	67.23	45.79	36.13	3.82	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	244.16	39.14	0.00	55.30	27.99	22.07	0.91	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	177.52	15.70	0.00	21.74	18.11	15.10	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	226.51	75.24	0.00	33.65	15.90	17.49	9.27	0.00	4.24
Smooth Muscle Cells - Prostate, donor1	11257-116F6	206.13	45.27	0.27	24.10	17.58	17.71	2.40	0.00	1.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	239.04	76.88	0.00	45.83	22.54	21.91	5.26	0.00	2.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	172.24	28.41	1.01	36.02	15.22	16.49	0.76	0.00	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	178.67	24.27	0.00	49.76	23.52	21.56	1.66	0.00	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	93.77	16.50	0.00	27.76	9.75	7.50	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1072.54	65.90	2.58	9.05	126.64	10.34	9.05	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	156.73	26.97	0.00	38.60	17.67	22.32	1.86	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	211.55	43.92	0.00	66.64	28.78	26.25	3.03	0.00	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	243.19	39.49	0.00	55.78	33.22	38.55	0.63	0.00	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	155.17	21.83	0.00	35.69	19.76	20.94	0.59	0.00	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	196.85	53.32	0.08	37.49	22.66	14.33	4.00	0.00	1.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	170.05	86.89	0.00	27.56	7.47	6.54	5.61	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	148.24	22.45	0.00	33.68	20.00	25.47	0.58	0.00	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	113.71	36.46	0.00	24.99	11.47	9.43	0.25	0.00	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	81.98	21.25	0.00	12.60	6.96	6.21	0.38	0.00	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	176.22	59.53	0.00	23.90	14.53	6.15	4.19	0.00	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	258.74	55.38	0.00	28.82	14.33	13.74	4.27	0.00	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	93.81	26.67	0.00	9.05	6.19	2.38	1.90	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	165.88	27.40	0.00	29.85	16.88	20.80	1.47	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	185.15	32.70	0.22	23.64	13.92	24.53	1.55	0.00	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	84.85	25.75	0.88	19.60	9.07	6.44	0.88	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	115.26	98.35	0.39	9.13	6.80	10.11	5.05	0.00	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	236.16	47.60	1.06	32.53	17.98	32.26	1.32	0.00	6.08
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	138.36	19.34	1.12	16.37	10.79	15.62	0.37	0.00	3.35
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	272.38	67.91	1.08	55.34	24.79	51.74	3.95	0.00	4.67
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	214.91	67.57	1.14	38.61	21.01	44.00	2.27	0.00	3.69
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	170.55	72.08	0.39	14.18	8.67	17.33	3.94	0.00	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	149.83	37.08	0.25	24.63	12.19	23.62	3.30	0.00	3.05
Smooth muscle cells - airway, control, donor2	11967-126D5	118.60	79.86	0.00	24.36	7.59	11.18	4.39	0.00	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	137.94	50.16	0.00	15.88	10.03	15.88	3.34	0.00	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	150.80	78.38	0.00	9.63	8.71	8.71	7.33	0.00	2.29
Synoviocyte, donor1	11291-117A4	263.42	29.46	0.34	40.23	21.21	25.58	1.01	0.00	2.52
Synoviocyte, donor2	11368-117I9	213.39	22.80	0.34	54.98	16.76	15.42	1.68	0.00	1.68
Synoviocyte, donor3	11440-118H9	178.50	17.65	0.22	37.31	13.85	16.53	0.67	0.00	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	125.78	75.40	0.00	11.08	5.72	7.86	4.29	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	174.42	49.55	0.00	17.84	19.82	15.86	3.96	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	101.19	42.84	0.00	9.72	6.02	6.02	4.40	0.00	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	68.17	17.78	0.22	14.05	7.10	4.44	0.65	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	62.62	17.78	0.77	10.44	3.48	3.48	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	64.14	10.31	0.57	7.44	5.15	3.44	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.46	32.85	207.79	12.55	8.86	3.69	4.80	31.99	0.62
Urethra, donor2	10319-105A4	104.31	89.92	61.15	21.58	8.99	1.80	8.99	8.99	7.19
Urothelial Cells, donor1	11520-119H8	145.05	20.46	0.27	19.13	12.22	11.95	1.06	0.00	0.27
Urothelial Cells, donor2	11600-120H7	89.33	24.84	0.00	15.62	7.21	5.61	1.20	0.00	0.80
Urothelial Cells, donor3	11681-122H7	105.21	13.98	0.46	12.61	5.96	3.21	1.15	0.23	1.38
Urothelial cells, donor0	11216-116B1	151.35	28.53	3.79	18.05	11.81	5.80	1.34	0.00	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	66.73	32.03	19.58	13.35	4.45	2.67	0.89	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	72.91	42.89	18.58	11.44	7.15	1.43	2.86	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	43.81	50.65	8.21	12.32	4.79	2.74	7.53	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	39.25	27.55	5.51	12.74	3.79	4.13	3.10	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.25	33.12	6.97	11.04	2.91	2.32	2.32	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	54.14	34.36	10.41	10.41	7.29	3.12	4.16	0.00	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	49.56	26.62	18.36	10.10	8.26	4.59	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	38.34	43.82	10.95	12.78	5.48	1.83	6.39	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	29.61	71.30	0.25	13.57	2.96	4.07	5.55	0.00	1.97
Wilms' tumor cell line:HFWT	10597-108E3	51.92	26.40	0.88	28.16	8.80	5.28	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	88.26	41.62	0.00	22.07	5.87	3.91	2.51	0.00	0.56
achilles tendon, donor2	10292-104G4	53.73	41.33	4.13	0.00	4.13	4.13	6.20	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	34.42	20.65	4.08	9.18	2.80	2.29	5.10	1.02	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	43.88	19.50	0.70	16.25	5.80	5.34	2.55	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	107.55	138.06	0.36	8.55	9.50	3.56	27.18	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	42.99	40.82	0.27	11.70	2.18	2.45	6.53	0.00	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	36.54	45.82	2.53	6.75	3.09	1.41	5.06	0.00	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	40.39	38.91	0.42	3.38	1.48	1.06	2.96	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	60.98	56.89	0.00	11.43	6.53	1.09	2.45	0.27	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	44.50	37.45	0.88	6.17	1.76	0.88	3.53	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	37.57	59.62	4.08	3.27	4.90	1.23	5.72	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	41.94	22.52	0.78	9.71	3.88	2.72	2.72	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	28.89	32.75	0.00	8.83	3.13	2.21	2.76	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	42.91	3.90	15.60	0.00	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	24.63	44.62	0.93	4.88	1.86	1.39	4.18	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	35.47	24.08	0.00	9.84	0.52	2.33	0.78	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	30.10	23.38	0.58	9.64	2.05	4.09	1.46	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	61.81	60.88	0.46	4.65	3.72	2.79	2.79	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.92	32.08	0.00	7.81	2.06	6.99	2.06	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.94	32.23	0.92	7.67	2.15	1.53	0.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	50.78	24.32	0.85	9.81	4.69	3.41	1.71	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	51.86	19.41	2.73	8.49	3.94	3.64	1.52	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	54.64	28.64	4.09	12.52	6.74	1.93	3.37	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	52.34	57.02	0.22	7.57	3.56	1.56	4.45	0.00	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	43.69	56.37	0.67	6.67	0.33	0.67	4.67	0.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	35.31	169.10	0.00	14.87	9.29	0.00	13.01	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	29.38	36.16	8.29	5.65	2.26	0.75	4.52	1.13	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.97	68.91	0.87	4.80	2.62	0.00	7.85	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	140.58	1.87	9.37	0.00	0.00	16.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	41.68	38.15	60.99	10.60	3.53	4.00	2.59	3.06	1.18
adipose tissue, adult, pool1	10010-101C1	216.55	39.25	50.88	34.13	30.87	16.44	2.79	3.26	0.93
adipose, donor1	10184-103D4	36.94	54.54	0.00	41.05	14.07	9.38	6.45	0.00	2.35
adipose, donor2	10185-103D5	15.00	75.02	0.00	19.06	3.24	4.06	20.68	0.00	0.81
adipose, donor3	10186-103D6	26.14	96.39	0.27	19.33	6.53	4.36	16.88	0.00	1.09
adipose, donor4	10187-103D7	29.47	85.81	0.87	13.00	6.07	2.60	16.47	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	39.77	88.06	0.63	17.04	7.26	1.89	8.36	0.00	0.79
adrenal gland, adult, pool1	10081-102A9	112.77	40.01	18.19	18.19	3.64	14.55	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	77.64	32.28	0.13	17.88	8.14	3.87	5.87	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	327.64	110.41	0.36	62.88	28.23	21.08	4.64	0.00	5.72
amniotic membrane cells, donor1	12235-129G3	198.46	18.32	1.39	19.01	7.88	8.58	0.93	0.23	1.62
amniotic membrane cells, donor2	12236-129G4	95.35	35.50	11.16	6.09	1.69	3.38	3.04	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	201.21	32.70	0.88	3.83	7.07	1.47	1.47	0.00	0.29
amygdala - adult, donor10196	10167-103B5	151.78	101.98	607.13	26.09	9.49	17.79	9.49	37.95	4.74
amygdala, adult, donor10252	10151-102I7	234.60	116.39	371.88	33.46	15.21	9.33	16.22	14.40	4.66
amygdala, newborn, donor10223	10360-105E9	108.13	107.80	87.47	17.11	10.65	11.62	12.91	6.13	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	262.94	106.96	0.00	20.25	17.95	8.02	9.68	0.00	2.55
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.36	25.59	0.00	10.37	2.87	2.21	1.99	0.00	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	7.68	161.01	0.00	3.01	0.00	3.34	24.38	0.00	1.00
aorta, adult, pool1	10052-101G7	82.57	111.40	4.51	7.06	2.94	3.33	9.02	0.00	1.37
appendix, adult	10189-103D9	60.93	48.13	12.42	12.03	6.60	6.21	4.66	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	17.20	47.81	94.24	7.91	1.38	0.34	12.38	6.19	0.69
artery, adult	10190-103E1	38.04	29.89	323.37	9.51	8.15	6.79	1.36	47.55	5.43
astrocytoma cell line:TM-31	10425-106D2	72.29	48.68	0.14	14.20	8.98	5.94	6.66	0.00	0.58
b cell line:RPMI1788	10427-106D4	30.63	13.98	13.23	6.25	1.64	2.08	2.83	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	304.08	41.34	3.05	49.11	24.69	43.28	1.39	0.00	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	130.69	33.04	0.10	16.67	8.63	5.95	1.89	0.00	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	81.18	19.42	1.67	7.87	3.51	2.68	1.67	0.50	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.86	33.00	0.00	6.71	2.80	0.00	3.36	0.00	0.00
bladder, adult, pool1	10011-101C2	161.55	68.23	22.16	19.88	13.25	7.71	8.04	1.74	1.09
blood, adult, pool1	10053-101G8	35.43	19.93	6.64	2.21	2.21	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	240.63	19.70	0.00	30.83	17.13	11.99	0.00	0.00	0.86
bone marrow, adult	10192-103E3	108.65	41.84	41.16	20.92	7.42	9.45	3.37	1.35	3.37
brain, adult, donor1	10084-102B3	68.68	52.28	193.74	21.53	8.20	10.25	3.08	17.43	2.05
brain, adult, pool1	10012-101C3	177.95	77.06	496.10	47.88	21.05	16.82	15.37	17.37	3.56
brain, fetal, pool1	10085-102B4	90.83	112.20	18.70	10.69	2.67	5.34	16.03	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	52.53	47.24	4.96	3.96	1.32	2.64	7.60	0.99	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	46.93	24.96	10.11	2.62	1.75	1.00	3.12	1.62	0.37
breast, adult, donor1	10080-102A8	200.14	92.18	17.68	18.94	22.73	8.21	7.58	1.89	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	18.42	20.83	14.48	29.35	1.65	6.10	1.14	1.52	1.27
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	62.77	57.82	0.00	21.03	4.02	4.33	4.02	0.00	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	105.67	22.10	0.69	29.47	8.06	5.76	2.53	0.00	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.00	31.71	11.14	3.39	0.48	2.18	2.66	0.97	0.97
carcinoid cell line:NCI-H1770	10703-109H1	34.79	137.29	0.47	5.64	3.76	0.00	24.92	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	125.46	120.43	0.55	17.28	11.05	4.59	13.67	0.00	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	61.79	83.03	9.51	10.14	3.17	1.27	16.48	1.90	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	36.73	107.00	0.27	5.32	2.93	2.66	18.10	0.00	1.33
caudate nucleus - adult, donor10196	10177-103C6	126.65	134.70	591.78	5.76	5.76	5.76	23.03	24.18	4.61
caudate nucleus, adult, donor10252	10164-103B2	116.12	77.47	407.27	17.74	6.02	3.35	12.72	12.21	2.84
caudate nucleus, adult, donor10258	10379-105H1	68.01	66.48	450.84	12.23	3.06	1.53	15.28	27.51	1.53
caudate nucleus, newborn, donor10223	10354-105E3	90.09	167.37	116.46	16.85	9.89	11.35	28.93	15.75	0.37
cerebellum - adult, donor10196	10173-103C2	72.83	221.41	381.64	2.91	5.83	2.91	26.22	34.96	2.91
cerebellum, adult, donor10252	10166-103B4	117.00	155.86	266.46	17.93	5.98	4.70	20.92	32.88	1.28
cerebellum, adult, pool1	10083-102B2	34.15	66.23	150.40	8.28	2.07	3.10	8.97	19.32	3.45
cerebellum, newborn, donor10223	10357-105E6	72.23	118.73	156.92	19.10	8.30	18.27	13.28	24.91	3.32
cerebral meninges, adult	10188-103D8	138.17	63.54	375.18	40.59	12.35	15.88	7.82	26.73	1.51
cerebrospinal fluid, donor2	10294-104G6	41.66	27.77	229.50	8.04	5.12	6.58	0.00	35.81	3.65
cervical cancer cell line:D98-AH2	10552-107I3	154.71	46.30	0.00	5.32	2.44	3.31	4.60	0.00	0.72
cervical cancer cell line:ME-180	10553-107I4	127.10	21.54	2.98	14.42	9.11	7.46	2.82	0.50	0.99
cervix, adult, pool1	10013-101C4	71.92	67.40	8.92	12.49	7.66	3.88	9.87	0.52	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	172.64	33.44	0.14	22.43	13.38	14.77	2.93	0.00	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	53.56	122.79	0.00	28.74	7.84	5.23	9.14	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	46.48	51.57	12.05	9.69	5.10	6.59	9.82	0.99	0.50
choriocarcinoma cell line:SCH	10785-110H2	21.81	67.40	63.33	2.71	0.62	1.23	8.01	4.19	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	42.93	87.76	88.94	4.51	4.51	4.51	13.76	9.25	0.71
chorionic membrane cells, donor1	12238-129G6	115.39	14.25	7.69	21.08	7.69	13.96	1.14	0.00	1.42
chorionic membrane cells, donor2	12239-129G7	183.15	45.34	2.29	25.35	11.34	11.83	3.38	0.00	0.99
chorionic membrane cells, donor3	12240-129G8	147.26	30.22	31.87	17.58	15.94	27.47	1.10	2.75	4.95
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	41.40	25.25	0.00	6.06	2.02	0.00	5.05	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	37.84	39.57	0.96	13.25	4.03	3.27	1.73	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	29.35	34.63	1.69	9.93	3.80	1.90	1.27	0.00	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	69.85	74.73	0.00	6.93	2.57	4.11	8.73	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	80.06	81.27	0.00	13.30	4.35	4.84	8.22	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	95.70	91.83	0.00	13.44	4.07	5.09	8.14	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	57.42	34.16	0.59	23.56	5.30	6.77	3.53	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.79	26.84	1.82	5.21	2.61	1.30	3.39	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	83.66	67.20	0.46	15.09	5.03	4.57	9.14	0.00	3.43
clear cell carcinoma cell line:TEN	10636-108I6	162.40	55.70	0.17	27.07	12.67	5.73	3.47	0.17	2.08
colon carcinoma cell line:CACO-2	10513-107D9	59.67	61.69	1.65	8.05	7.14	1.65	6.96	0.37	0.55
colon carcinoma cell line:COLO-320	10420-106C6	42.95	77.92	0.00	8.36	2.28	2.28	11.78	0.00	0.00
colon, adult, donor1	10082-102B1	55.93	38.08	26.18	3.57	4.76	3.57	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	91.30	53.93	52.05	13.87	9.64	5.64	5.17	4.11	0.47
colon, fetal, donor1	10070-101I7	43.88	32.14	58.09	6.80	4.33	1.85	4.94	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	73.34	110.00	0.00	22.92	4.58	27.50	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	21.67	7.22	0.00	10.20	3.82	6.37	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	41.05	7.09	0.00	17.96	9.51	9.51	0.15	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	37.51	7.19	0.00	16.92	10.01	5.50	0.28	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	333.68	114.76	40.13	29.41	44.78	9.62	14.48	2.10	1.33
cruciate ligament, donor2	10295-104G7	90.77	45.39	15.40	7.29	2.43	4.05	2.43	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	33.71	33.71	180.58	6.42	0.80	4.01	2.41	14.45	2.41
diencephalon, adult	10193-103E4	175.43	114.47	278.15	20.64	15.36	9.12	15.12	11.52	3.36
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.52	10.56	0.46	6.89	2.07	2.53	0.69	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	30.00	13.08	0.26	9.23	2.82	2.56	0.51	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	61.14	19.74	0.24	9.39	4.09	2.41	2.17	0.00	0.72
ductus deferens, adult	10196-103E7	64.29	42.36	36.88	12.46	2.99	1.50	6.48	1.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	20.16	41.77	7.20	2.88	1.44	5.76	4.32	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	39.73	56.64	62.53	4.41	2.94	2.21	3.68	6.62	4.41
dura mater, adult, donor1	10041-101F5	130.07	58.97	11.23	23.45	10.90	8.59	4.62	0.91	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	34.64	20.21	0.67	6.22	5.77	6.22	3.11	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	47.14	28.80	0.72	10.32	3.87	7.59	3.58	0.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	146.14	167.72	0.00	33.30	12.95	22.20	8.63	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	167.70	70.53	0.30	32.09	15.44	14.53	2.72	0.00	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	172.90	125.04	0.00	33.04	14.82	25.01	10.50	0.00	0.93
embryonic pancreas cell line:2C6	10603-108E9	116.90	105.08	0.00	28.90	13.13	9.19	9.19	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	84.80	75.75	0.00	14.41	3.02	4.69	7.37	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	75.03	46.22	0.00	10.69	3.99	5.62	6.52	0.00	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.92	45.99	1.29	4.02	1.61	0.48	4.99	0.00	0.64
epidermoid carcinoma cell line:A431	10426-106D3	89.04	34.46	7.11	9.78	4.22	3.67	3.45	0.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	144.52	64.45	0.00	18.26	8.80	7.37	5.06	0.00	0.66
epididymis, adult	10197-103E8	66.56	36.00	67.82	12.14	4.19	4.60	6.91	4.81	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	136.25	39.03	28.03	47.90	18.98	16.68	3.73	1.77	1.60
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	52.30	36.18	1.97	13.37	5.11	3.93	3.54	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	114.67	21.36	0.00	12.97	4.72	3.80	1.44	0.00	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	124.99	30.41	0.00	14.96	5.61	3.44	2.85	0.00	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	104.97	25.99	0.00	14.12	4.03	4.59	1.34	0.00	0.67
esophagus, adult, pool1	10015-101C6	108.73	34.93	25.38	19.86	13.06	7.11	3.72	2.34	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	154.54	60.86	0.00	95.05	32.31	89.92	9.77	0.00	0.75
eye - muscle inferior rectus, donor1	10272-104E2	94.17	43.46	224.56	19.32	2.41	4.83	2.41	24.15	2.41
eye - muscle lateral, donor2	10298-104H1	48.40	12.63	347.19	14.73	6.31	2.10	0.00	31.56	12.63
eye - muscle medial, donor2	10299-104H2	25.30	32.74	278.30	7.44	0.00	0.00	2.98	29.76	1.49
eye - muscle superior, donor2	10297-104G9	38.98	40.13	190.32	6.88	4.59	3.44	3.44	11.46	5.73
eye - vitreous humor, donor1	10268-104D7	78.70	36.43	32.06	14.57	17.49	5.83	1.46	11.66	0.00
eye, fetal, donor1	10054-101G9	98.39	81.10	87.46	11.44	12.46	4.32	11.19	8.64	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	100.91	43.21	0.00	17.31	6.54	5.90	2.56	0.00	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	117.05	53.18	0.00	39.89	10.68	7.36	4.99	0.00	2.37
frontal lobe, adult, pool1	10040-101F4	170.20	72.43	685.20	44.00	20.74	18.48	11.26	33.03	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	97.28	59.15	9.91	6.61	2.40	3.00	3.60	0.90	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	163.21	27.80	0.00	54.13	16.00	16.46	1.65	0.00	0.64
gall bladder, adult	10198-103E9	114.20	72.43	8.45	20.28	10.14	4.10	6.28	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	27.38	16.11	3.76	12.88	3.76	2.15	1.61	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	39.96	18.30	15.31	11.58	4.11	4.48	1.12	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	96.31	34.85	0.00	13.52	3.80	8.03	3.80	0.00	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	78.72	53.00	5.42	11.41	7.35	5.22	3.67	0.19	1.16
gastric cancer cell line:AZ521	10549-107H9	46.24	20.49	0.00	21.81	5.57	9.35	1.64	0.00	0.66
gastric cancer cell line:GSS	10560-108A2	28.37	30.20	0.00	7.32	3.66	3.66	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	98.46	119.25	3.43	10.51	5.71	3.20	21.93	0.23	1.14
giant cell carcinoma cell line:LU65	10487-107B1	65.17	10.21	0.00	5.74	5.16	2.87	0.23	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	320.09	132.96	2.80	54.58	24.77	11.90	10.08	0.28	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	56.62	23.20	3.99	5.49	2.74	2.74	1.25	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	118.64	24.91	0.63	28.60	8.23	11.93	2.96	0.11	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	106.59	24.16	0.28	33.28	6.60	8.57	4.35	0.00	0.70
glioblastoma cell line:T98G	10485-107A8	155.96	49.23	0.00	24.28	7.84	10.04	4.97	0.00	1.21
glioma cell line:GI-1	10413-106B8	164.60	58.28	0.00	17.28	15.23	4.69	5.27	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	129.75	140.68	224.50	5.10	10.20	5.83	11.66	12.39	2.19
globus pallidus, adult, donor10252	10161-103A8	369.07	140.35	90.56	27.34	25.63	5.37	14.40	3.17	2.20
globus pallidus, adult, donor10258	10367-105F7	245.09	208.12	124.60	10.95	26.01	2.74	16.43	9.58	2.74
globus pallidus, newborn, donor10223	10364-105F4	84.73	116.18	86.87	18.65	11.72	6.93	15.45	10.66	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	75.86	58.73	0.00	36.71	12.24	17.13	9.79	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	10.93	0.00	32.79	21.86	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	20.91	5.23	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	164.16	115.84	0.32	18.56	8.00	6.40	12.16	0.00	0.96
hIPS +CCl2, biol_rep1	14383-156B9	34.43	83.10	11.02	4.59	0.92	2.75	13.77	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	36.58	77.28	17.83	1.83	0.00	2.74	8.69	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	40.58	105.63	10.31	1.93	1.93	1.29	12.24	0.64	0.64
hIPS, biol_rep1	14380-156B6	15.81	158.10	0.00	0.00	1.44	4.31	8.62	0.00	1.44
hIPS, biol_rep2	14381-156B7	18.52	104.94	4.12	1.37	1.37	1.37	11.66	0.00	2.06
hIPS, biol_rep3	14382-156B8	97.11	145.66	285.80	3.31	0.00	3.31	15.45	16.55	1.10
hairy cell leukemia cell line:Mo	10712-109I1	29.88	14.37	0.29	4.02	2.30	0.57	2.30	0.00	0.00
heart - mitral valve, adult	10205-103F7	102.55	40.96	3.59	11.66	8.37	3.59	3.59	0.00	2.39
heart - pulmonic valve, adult	10206-103F8	68.51	51.25	15.95	5.75	6.28	3.14	5.75	0.78	1.83
heart - tricuspid valve, adult	10207-103F9	160.70	51.62	0.00	21.65	20.82	5.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	51.83	34.08	8.16	7.75	2.04	3.26	4.29	1.22	1.22
heart, adult, diseased, donor1	10051-101G6	60.89	20.44	2.55	3.83	2.55	1.28	4.26	0.43	1.28
heart, adult, pool1	10016-101C7	74.51	25.30	0.23	17.48	8.51	5.29	1.61	0.00	0.46
heart, fetal, pool1	10046-101G1	82.25	63.05	0.82	14.27	7.29	5.85	10.99	0.00	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	180.18	59.55	0.00	34.25	10.18	16.04	4.01	0.00	2.78
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	33.30	0.00	2.38	1.19	2.38	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	103.53	106.74	0.00	15.25	6.52	5.52	9.83	0.00	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	116.88	106.08	0.00	18.33	7.28	4.37	9.71	0.00	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	115.91	111.66	0.10	18.69	6.97	3.64	8.39	0.00	0.40
hepatoma cell line:Li-7	10484-107A7	174.94	69.06	0.33	12.90	11.23	7.56	10.57	0.00	1.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	31.36	27.24	11.76	6.73	2.21	1.41	2.91	1.21	0.10
hippocampus - adult, donor10196	10169-103B7	117.34	117.34	323.64	17.98	8.52	8.52	5.68	20.82	0.95
hippocampus, adult, donor10252	10153-102I9	217.57	108.17	236.14	21.02	11.63	6.12	14.90	8.98	3.88
hippocampus, adult, donor10258	10374-105G5	127.97	76.19	365.00	4.98	1.49	6.97	3.49	15.44	3.49
hippocampus, newborn, donor10223	10363-105F3	189.63	93.41	41.59	22.91	15.86	21.50	7.05	5.29	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	33.57	89.72	0.00	8.54	4.27	3.05	16.48	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.69	102.69	0.00	8.64	2.75	2.36	20.42	0.00	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	26.15	105.11	0.00	12.69	5.59	4.82	22.85	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	19.17	63.72	0.56	24.81	10.15	6.77	10.71	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	27.63	71.01	0.00	32.53	10.84	6.20	12.39	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.40	66.43	0.00	37.58	11.01	14.05	11.39	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	26.28	93.72	0.00	20.14	11.39	5.84	14.31	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.01	119.99	0.43	18.10	8.62	4.95	21.54	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.03	98.85	0.83	14.18	10.01	8.34	15.85	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	47.60	80.75	0.95	23.92	9.00	6.39	12.79	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.70	114.11	0.32	23.46	11.25	7.39	19.93	0.32	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	49.82	66.66	0.67	21.55	8.75	10.10	12.12	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	40.53	114.86	0.00	12.68	5.63	4.23	23.63	0.00	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	95.80	0.00	6.39	4.42	1.97	16.21	0.00	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.89	75.06	0.00	10.47	6.11	5.24	12.22	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	29.97	74.46	0.00	43.15	11.65	8.02	15.85	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	19.19	73.26	0.00	20.93	6.54	6.54	12.65	0.00	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	24.49	67.47	0.00	26.49	15.49	10.49	8.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.62	73.28	0.57	15.64	4.33	3.01	16.58	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.00	73.66	0.00	13.19	4.09	3.64	15.92	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.77	72.67	0.63	10.96	2.51	2.19	17.54	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	29.23	97.00	1.14	21.72	7.02	5.72	14.21	0.16	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.03	89.12	0.87	16.84	6.68	5.81	13.35	0.00	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.31	108.51	0.30	23.32	3.89	12.85	18.23	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.50	102.53	0.00	15.33	6.65	3.69	19.77	0.00	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	37.09	101.56	0.00	13.41	4.85	4.56	14.26	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	41.65	97.18	0.00	10.62	6.12	4.08	15.92	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.04	71.47	0.70	16.90	6.34	5.63	16.90	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.49	72.85	0.63	20.90	6.02	4.43	16.15	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	28.14	72.33	0.30	25.72	8.17	4.54	11.80	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	15.00	86.36	1.55	20.17	3.10	3.62	12.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	16.60	73.72	1.99	10.63	4.65	4.65	12.62	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.04	66.95	0.51	15.65	4.62	4.62	13.60	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.35	87.18	0.51	13.55	6.90	7.93	9.46	0.00	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	37.10	109.80	0.00	15.90	6.82	4.54	14.39	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	32.26	86.03	0.34	17.14	8.74	12.43	11.76	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	36.95	114.23	0.00	17.87	4.11	4.11	19.08	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	42.34	105.62	0.00	20.95	10.25	5.35	16.04	0.00	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	32.20	113.66	0.00	11.71	6.34	6.34	18.05	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	39.73	79.77	0.00	31.48	9.17	5.20	14.36	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	71.57	0.00	32.53	16.27	13.01	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	29.78	51.63	0.00	28.13	12.58	6.95	12.91	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	29.55	85.93	0.00	18.61	5.47	5.47	16.42	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	22.44	89.75	0.00	15.20	9.05	3.98	18.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.42	71.53	0.00	17.08	9.61	4.98	8.54	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	52.51	79.96	0.00	20.29	8.35	13.13	10.74	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	57.42	93.44	0.27	30.47	18.96	15.57	13.00	0.00	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.94	85.40	0.00	20.20	6.47	9.97	11.58	0.00	0.27
immature langerhans cells, donor1	11904-125F5	64.65	18.65	1.45	10.17	5.09	5.09	2.42	0.00	0.48
immature langerhans cells, donor2	11905-125F6	201.99	47.53	1.58	19.01	26.93	5.54	2.38	0.79	1.58
insula, adult, pool1	10039-101F3	151.41	65.77	481.97	43.82	17.13	21.48	13.91	26.78	1.32
keratoacanthoma cell line:HKA-1	10791-110H8	66.33	32.19	10.40	9.43	2.28	2.93	2.28	0.00	1.30
kidney, adult, pool1	10017-101C8	61.98	80.50	116.65	9.91	4.41	4.71	13.62	29.74	1.30
kidney, fetal, pool1	10045-101F9	44.85	91.32	28.51	7.64	3.61	3.96	16.91	6.22	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	102.54	56.38	0.00	15.05	8.81	5.40	3.83	0.00	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	151.51	20.74	0.69	8.71	6.50	3.73	0.83	0.14	2.49
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	102.76	90.65	0.00	9.17	5.50	2.02	10.83	0.00	0.55
left atrium, adult, donor1	10079-102A7	54.49	64.29	3.27	7.08	4.36	1.09	8.72	0.00	3.27
left ventricle, adult, donor1	10078-102A6	71.80	36.41	0.51	6.07	4.55	2.53	2.53	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	105.89	121.48	0.27	26.81	6.29	2.46	10.40	0.00	1.37
leiomyoma cell line:10964C	10569-108B2	202.26	43.47	1.08	75.08	23.35	29.82	3.59	0.00	3.23
leiomyoma cell line:15242A	10570-108B3	255.44	34.78	0.00	86.41	25.00	46.20	1.63	0.54	3.80
leiomyoma cell line:15425	10571-108B4	221.93	42.74	1.21	70.66	25.25	39.09	2.19	0.00	5.83
leiomyosarcoma cell line:Hs 5.T	10722-110A2	298.42	25.40	0.00	19.05	50.79	19.05	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	102.46	64.82	0.00	13.59	3.14	9.41	4.18	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	57.14	41.67	0.00	7.44	3.78	2.36	1.89	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	192.14	87.32	2.34	40.61	14.53	9.84	4.22	0.16	2.66
liposarcoma cell line:SW 872	10726-110A6	85.53	83.58	0.00	13.16	3.66	4.26	5.60	0.00	0.73
liver, adult, pool1	10018-101C9	11.18	9.24	140.67	1.46	0.81	0.97	2.27	16.69	0.32
liver, fetal, pool1	10086-102B5	5.64	16.93	41.39	0.00	1.88	2.82	1.88	3.76	0.94
locus coeruleus - adult, donor10196	10182-103D2	196.43	167.99	231.42	24.94	16.33	14.14	21.87	8.90	5.10
locus coeruleus, adult, donor10252	10165-103B3	266.12	135.28	136.94	22.33	16.06	7.75	17.72	3.51	3.32
locus coeruleus, adult, donor10258	10375-105G6	124.42	118.50	95.64	20.60	12.98	9.31	11.29	1.69	5.92
locus coeruleus, newborn, donor10223	10362-105F2	136.28	68.14	115.25	9.67	21.03	10.52	6.73	9.67	1.68
lung adenocarcinoma cell line:A549	10499-107C4	93.83	26.71	1.25	16.47	5.95	6.09	3.32	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	80.66	31.71	0.00	23.44	6.20	9.65	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	80.01	29.92	0.00	34.40	6.59	6.99	3.95	0.00	0.53
lung, adult, pool1	10019-101D1	152.38	74.18	14.88	20.91	20.91	5.91	9.69	1.18	1.30
lung, fetal, donor1	10068-101I5	104.46	78.77	22.26	7.14	6.56	7.14	6.85	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	87.06	62.32	14.66	14.20	10.54	5.04	8.25	0.92	2.29
lymph node, adult, donor1	10077-102A5	60.59	44.97	1.42	12.78	5.68	1.89	1.89	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	17.75	20.82	0.00	3.07	0.44	0.22	3.95	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	15.09	7.85	13.43	8.45	2.11	3.02	1.06	0.75	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	95.99	17.84	3.40	24.64	12.74	22.09	0.85	1.70	0.85
mature adipocyte, donor1	12231-129F8	264.62	60.38	228.65	58.61	25.75	20.42	4.44	16.87	0.44
mature adipocyte, donor2	12232-129F9	307.14	65.99	227.04	57.07	24.49	17.22	4.57	15.36	0.83
mature adipocyte, donor3	12233-129G1	364.60	44.09	247.97	55.24	27.03	18.73	2.37	11.62	0.95
mature adipocyte, donor4	12234-129G2	272.96	41.06	283.49	36.32	13.95	11.84	2.11	17.90	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	32.64	16.68	0.95	19.54	5.96	10.72	2.14	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	121.83	87.99	752.40	21.43	7.90	12.41	10.15	33.84	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	210.94	91.03	497.47	30.90	10.30	9.01	10.85	13.43	2.76
medial frontal gyrus, adult, donor10258	10368-105F8	90.22	109.92	460.96	16.20	5.72	8.90	13.98	22.24	4.45
medial frontal gyrus, newborn, donor10223	10352-105E1	159.51	53.31	324.13	22.18	10.66	17.91	11.09	24.74	3.84
medial temporal gyrus - adult, donor10196	10183-103D3	140.23	89.27	882.40	34.43	8.10	13.16	13.67	41.51	9.79
medial temporal gyrus, adult, donor10252	10156-103A3	246.61	107.60	557.73	28.23	12.31	8.49	12.31	17.19	3.82
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	69.35	98.24	566.32	7.71	1.93	5.78	3.85	25.04	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	703.33	200.95	10406.37	71.77	71.77	57.41	14.35	416.25	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	139.98	117.01	122.75	26.92	11.13	26.56	12.56	8.61	2.87
medulla oblongata - adult, donor10196	10174-103C3	92.80	117.47	138.88	5.19	3.89	3.89	16.22	4.54	3.89
medulla oblongata, adult, donor10252	10155-103A2	234.99	143.19	121.83	20.74	15.48	5.88	18.58	6.04	2.48
medulla oblongata, adult, pool1	10038-101F2	185.13	99.59	109.38	28.81	24.00	17.39	14.37	5.47	0.82
medulla oblongata, newborn, donor10223	10361-105F1	91.31	81.59	48.61	17.01	8.33	11.80	9.03	2.78	1.04
medulloblastoma cell line:D283 Med	10838-111E1	37.64	57.35	50.04	4.65	0.89	1.11	9.52	16.38	0.44
medulloblastoma cell line:ONS-76	10759-110E3	111.51	67.37	0.00	25.68	6.24	4.77	5.50	0.00	1.35
melanoma cell line:COLO 679	10514-107E1	57.64	59.37	2.87	12.94	5.03	8.19	7.76	0.00	0.14
melanoma cell line:G-361	10465-106H6	38.28	34.20	3.80	11.40	1.36	8.42	2.44	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	214.73	47.40	0.00	31.30	20.98	18.45	3.80	0.00	3.98
merkel cell carcinoma cell line:MKL-1	10843-111E6	79.30	146.27	0.00	13.22	4.41	8.81	16.74	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	47.70	89.17	0.26	7.52	3.63	3.11	17.11	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	137.17	16.42	0.46	26.39	13.20	11.51	0.46	0.00	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	101.43	9.63	0.00	11.45	9.45	9.27	0.73	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	158.60	12.84	0.41	19.88	11.18	16.15	0.83	0.00	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	204.67	31.47	0.00	23.32	18.12	13.49	1.69	0.00	1.83
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	136.34	35.24	0.39	14.06	10.40	6.55	2.31	0.00	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	183.93	24.99	0.00	35.40	15.27	27.07	1.39	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	432.35	47.71	0.00	46.17	46.86	49.60	1.20	0.00	2.75
mesenchymal precursor cell - cardiac, donor2	11753-123G7	243.14	25.88	0.12	21.51	22.08	17.83	0.46	0.00	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	135.42	17.91	0.27	18.44	10.88	7.43	0.80	0.00	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	150.57	18.91	0.00	23.63	16.74	12.56	1.22	0.00	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	174.84	36.70	0.00	16.64	13.51	9.53	1.56	0.00	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	154.14	43.47	0.00	31.95	12.84	22.73	1.65	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	123.70	34.45	0.14	16.05	7.47	9.69	1.80	0.00	1.25
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	164.07	22.69	0.35	28.62	12.92	15.01	1.40	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	171.50	24.30	0.20	21.23	12.25	15.72	1.22	0.00	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	184.40	40.98	0.36	28.76	12.58	21.21	2.52	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	115.86	37.14	0.31	10.14	6.83	4.66	1.76	0.00	1.34
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	236.88	36.02	0.23	41.04	17.10	28.95	2.05	0.00	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	223.20	27.27	0.00	28.53	11.75	22.66	0.84	0.42	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	109.99	18.98	0.15	14.79	7.32	9.12	1.05	0.00	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	182.59	42.19	0.18	16.89	13.83	9.63	1.31	0.00	1.66
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	205.43	37.55	0.00	28.72	12.89	16.94	1.47	0.00	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	183.43	33.48	0.00	36.91	13.16	19.74	2.29	0.00	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	252.19	77.47	0.42	56.84	23.58	18.95	6.32	0.42	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	137.00	15.98	0.46	19.18	8.22	10.05	1.37	0.00	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	149.89	17.39	1.02	28.39	10.74	11.77	2.05	0.00	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	153.65	25.13	1.05	34.55	7.33	14.40	1.83	0.26	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	150.35	21.26	0.00	36.66	14.48	18.79	0.92	0.31	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	139.80	15.77	0.24	26.83	8.71	16.00	0.94	0.00	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	154.67	17.26	1.02	35.54	11.17	20.31	2.03	0.00	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	133.22	14.93	0.79	35.76	9.04	17.68	0.79	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	123.72	15.76	0.46	30.12	14.36	16.68	1.39	0.00	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	289.82	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	154.01	19.90	0.29	40.09	13.84	15.86	0.58	0.29	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	149.70	16.29	0.45	41.72	12.49	18.29	0.45	0.22	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	150.22	14.42	0.72	35.09	12.98	16.82	0.72	0.24	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	156.20	22.00	0.73	45.47	12.47	19.07	0.73	0.00	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	131.91	13.09	0.67	29.87	9.73	14.43	1.01	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	141.24	18.01	0.82	23.33	7.78	18.83	1.23	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	119.42	13.75	0.43	31.79	13.75	18.47	0.43	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	112.11	8.20	2.73	21.88	13.67	19.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	98.13	5.16	0.00	20.66	10.33	5.16	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	125.37	16.24	0.00	25.33	8.44	14.29	0.65	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	101.85	11.64	0.00	33.46	7.27	14.55	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	120.48	10.13	1.07	26.12	6.40	18.66	1.60	0.53	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	108.76	9.81	0.82	23.72	13.08	16.36	0.00	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	128.67	12.83	0.39	28.38	10.11	10.50	1.17	0.39	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	128.02	14.69	0.00	25.18	8.39	16.79	2.10	0.00	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	119.22	13.91	0.99	14.90	9.93	10.93	1.99	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	133.48	9.53	0.00	23.84	4.77	9.53	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	115.04	10.08	0.59	15.42	6.52	13.05	1.19	0.59	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	114.54	12.18	0.00	26.81	10.97	12.18	1.22	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	162.31	81.16	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	104.51	10.77	2.53	26.60	11.40	13.30	0.00	0.00	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	82.43	13.11	1.03	11.73	6.55	6.21	0.34	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	60.18	15.04	2.15	12.90	6.45	8.60	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	67.86	11.98	0.00	0.00	7.98	7.98	0.00	0.00	15.97
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	10.33	3.44	10.33	6.89	3.44	3.44	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	61.94	14.26	1.22	6.93	4.48	4.07	2.44	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	63.56	20.66	2.38	4.77	3.18	3.18	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	72.51	18.86	1.77	10.61	3.54	5.31	0.00	0.59	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	63.28	19.01	1.25	10.29	2.18	6.23	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	84.21	24.06	2.67	6.68	5.35	1.34	4.01	0.00	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	88.70	20.11	4.73	9.46	2.37	7.10	1.18	0.00	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	87.31	30.82	10.27	10.27	5.14	5.14	0.00	0.00	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	94.31	22.72	13.08	11.01	5.51	4.82	0.69	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	148.44	51.46	84.61	14.35	7.42	8.91	0.99	3.96	3.96
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	121.12	47.10	52.71	10.09	7.85	8.97	1.12	1.12	5.61
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	134.21	46.43	64.24	23.53	5.09	9.54	3.18	7.00	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	189.00	77.78	100.34	28.21	10.48	16.52	5.24	4.03	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	180.99	87.22	82.86	41.43	6.54	23.99	0.00	8.72	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	163.45	76.02	60.82	21.54	7.60	11.40	1.27	2.53	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	214.84	76.47	51.59	21.85	19.42	14.57	6.07	4.25	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	207.87	72.30	54.23	18.08	31.63	22.59	13.56	0.00	40.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	180.39	70.01	51.07	24.71	9.88	14.00	2.47	1.65	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	70.24	14.49	16.67	17.86	8.14	7.74	1.59	1.39	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	89.56	25.63	16.22	16.87	5.84	7.14	0.00	0.97	2.92
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	90.66	21.39	14.26	17.32	5.09	10.19	0.00	0.00	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	147.01	50.29	0.00	23.21	13.15	8.51	6.19	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	138.67	47.01	0.71	27.17	11.58	9.92	4.25	0.00	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	49.35	50.27	6.26	9.73	1.85	4.40	6.95	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	239.32	42.74	0.00	21.37	4.27	8.55	0.00	0.00	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	213.93	49.83	1.44	18.60	12.64	12.43	4.73	0.00	2.47
mesothelioma cell line:Mero-25	10850-111F4	63.55	37.22	0.00	8.85	2.72	3.86	4.54	0.00	1.59
mesothelioma cell line:Mero-41	10851-111F5	145.95	51.10	0.00	32.27	8.56	17.60	3.42	0.00	2.44
mesothelioma cell line:Mero-48a	10852-111F6	136.84	72.19	0.00	18.82	5.54	5.31	4.43	0.00	1.33
mesothelioma cell line:Mero-82	10853-111F7	187.38	79.37	0.26	14.45	10.51	12.09	4.99	0.00	8.41
mesothelioma cell line:Mero-83	10854-111F8	234.05	82.39	0.68	24.17	13.11	10.89	4.77	0.17	3.40
mesothelioma cell line:Mero-84	10855-111F9	66.48	81.39	4.80	8.59	3.03	1.26	5.06	0.76	2.27
mesothelioma cell line:Mero-95	10856-111G1	85.30	76.81	0.00	10.97	3.31	5.38	4.97	0.00	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	370.72	73.05	0.00	43.40	22.36	25.18	3.98	0.00	5.14
mesothelioma cell line:NCI-H226	10846-111E9	122.17	31.67	0.36	28.42	10.50	22.99	1.99	0.00	1.99
mesothelioma cell line:NCI-H2452	10848-111F2	152.20	42.02	2.73	41.34	14.69	14.86	2.73	0.17	3.59
mesothelioma cell line:NCI-H28	10845-111E8	134.10	54.71	19.08	14.25	7.38	6.11	5.09	1.27	1.27
mesothelioma cell line:No36	10857-111G2	49.58	29.68	13.70	6.20	0.65	0.98	2.94	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	156.34	42.81	0.00	28.99	13.28	16.53	1.90	0.00	3.79
migratory langerhans cells, donor1	11901-125F2	95.00	30.32	0.38	15.93	9.60	5.76	0.77	0.00	0.96
migratory langerhans cells, donor2	11902-125F3	61.55	30.04	0.12	19.66	6.96	7.82	3.42	0.00	0.73
migratory langerhans cells, donor3	11903-125F4	62.46	37.69	0.00	11.85	5.74	3.41	3.95	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	69.54	62.36	0.00	3.26	3.92	3.59	9.79	0.00	3.59
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	72.06	81.17	0.42	8.05	2.76	1.27	4.03	0.00	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	100.67	85.23	0.00	13.59	6.45	4.84	5.99	0.00	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.97	9.70	0.00	11.42	4.19	4.00	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	79.09	30.68	0.00	15.15	7.21	4.62	2.96	0.00	0.55
myeloma cell line:PCM6	10474-106I6	45.66	7.31	0.40	13.64	4.35	6.13	0.59	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	103.99	147.11	0.00	4.06	2.54	1.52	12.68	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	135.14	23.93	0.20	30.60	5.49	14.71	0.39	0.00	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	83.46	17.16	0.33	13.04	5.68	3.79	0.67	0.00	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	76.34	15.81	0.37	11.18	5.07	3.90	1.32	0.00	0.51
nasal epithelial cells, donor2	12227-129F4	81.14	19.32	2.76	18.22	7.73	3.86	2.21	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	40.95	88.11	0.23	5.29	1.38	2.76	14.03	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	105.14	91.48	0.94	15.72	6.74	3.37	8.79	0.00	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	47.45	107.97	0.21	10.54	3.16	4.22	16.87	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	48.45	96.90	0.19	4.47	0.56	1.12	16.59	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	27.28	69.98	1.42	4.03	1.19	0.71	12.10	0.00	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	45.30	88.53	1.43	6.02	3.64	1.58	6.97	0.63	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	18.31	62.39	2.21	1.81	0.40	0.81	10.87	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.72	130.97	1.91	7.63	0.00	0.64	22.25	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	146.66	42.32	0.00	29.81	10.38	10.38	2.13	0.00	2.13
neutrophil PMN, donor1	12133-128D9	14.87	59.50	0.00	0.00	14.87	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	26.56	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	47.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	50.40	32.30	2.71	41.77	6.26	9.30	5.41	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	107.27	89.66	0.80	16.01	5.60	8.81	13.61	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	171.84	104.84	0.32	21.48	7.69	9.94	4.81	0.00	7.37
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	225.19	86.19	0.00	36.79	17.34	16.03	6.83	0.00	3.94
nucleus accumbens, adult, pool1	10037-101F1	145.67	73.96	478.91	34.59	17.15	13.50	13.97	23.25	1.50
occipital cortex - adult, donor10196	10172-103C1	125.68	119.50	968.38	16.48	4.12	16.48	14.42	24.72	4.12
occipital cortex, adult, donor10252	10163-103B1	292.25	97.68	366.85	29.79	14.49	6.98	12.61	6.71	5.37
occipital cortex, newborn, donor10223	10355-105E4	135.75	68.06	215.09	38.94	11.65	24.02	9.46	13.83	1.46
occipital lobe, adult, donor1	10076-102A4	168.98	71.90	429.02	54.32	14.43	16.79	12.86	23.88	5.51
occipital lobe, fetal, donor1	10073-102A1	245.87	210.69	0.43	17.16	9.01	12.44	33.04	0.43	6.87
occipital pole, adult, pool1	10036-101E9	117.00	44.86	265.07	30.43	11.75	11.51	7.88	15.53	0.47
olfactory region, adult	10195-103E6	164.69	68.21	423.18	22.93	9.17	9.55	7.64	13.18	4.39
optic nerve, donor1	10277-104E7	244.13	190.10	0.00	16.01	22.01	14.01	18.01	0.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	129.29	31.21	0.80	16.29	9.11	8.20	1.82	0.11	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	73.23	38.33	9.62	17.17	7.97	3.43	5.08	0.96	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	76.53	23.71	0.00	10.16	3.89	3.89	2.20	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	68.96	21.25	0.00	18.60	2.89	7.51	1.39	0.00	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	335.12	53.21	0.00	45.86	24.69	27.93	4.70	0.00	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	74.75	23.36	0.00	28.96	14.95	12.15	0.93	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	50.05	64.25	0.00	3.61	2.54	2.76	4.45	0.00	0.85
ovary, adult, pool1	10020-101D2	49.18	84.21	6.38	6.55	4.63	3.93	16.16	0.87	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	81.39	59.58	0.00	10.27	2.93	3.67	1.65	0.00	1.10
pancreas, adult, donor1	10049-101G4	15.99	28.22	21.63	2.82	0.00	0.94	5.64	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	24.88	40.81	123.00	9.50	2.80	8.67	2.80	19.29	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	131.17	47.02	0.00	11.41	5.45	7.33	3.92	0.00	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	73.19	56.63	1.66	22.19	12.09	8.94	4.14	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	182.59	76.33	445.25	47.77	21.97	20.87	12.90	21.23	1.28
parietal cortex, adult, donor10258	10373-105G4	95.42	92.48	427.93	3.67	2.94	3.67	10.28	21.29	2.94
parietal lobe - adult, donor10196	10171-103B9	113.80	94.99	543.60	18.81	8.46	11.29	15.05	26.33	4.70
parietal lobe, adult, donor10252	10157-103A4	209.79	82.95	543.85	29.07	9.41	10.55	7.70	12.26	2.57
parietal lobe, adult, pool1	10034-101E7	169.01	63.18	400.68	40.89	22.82	17.10	11.46	20.36	0.88
parietal lobe, fetal, donor1	10072-101I9	261.86	181.36	0.00	37.82	5.82	11.64	16.49	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	153.66	86.74	155.90	37.76	10.84	20.56	13.09	7.10	2.62
parotid gland, adult	10199-103F1	145.53	22.20	12.95	15.42	9.87	8.63	1.85	0.00	0.62
penis, adult	10200-103F2	88.09	41.89	145.56	8.06	6.45	2.15	1.61	15.58	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	25.66	29.75	1.12	3.90	1.30	0.93	5.39	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	53.62	61.05	24.77	18.36	6.85	4.23	5.10	1.46	1.17
pineal gland - adult, donor10196	10179-103C8	56.76	167.06	476.68	3.87	1.94	4.52	13.55	25.16	4.52
pineal gland, adult, donor10252	10160-103A7	54.48	108.97	684.01	10.66	3.55	2.37	23.10	52.71	1.78
pineal gland, adult, donor10258	10377-105G8	52.05	76.50	264.63	10.66	1.88	4.39	13.17	16.93	2.51
pituitary gland - adult, donor10196	10180-103C9	53.63	70.83	52.61	3.04	3.04	3.04	14.17	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	60.46	52.12	101.63	10.42	2.61	2.61	10.94	7.82	2.61
pituitary gland, adult, donor10258	10378-105G9	22.13	34.90	39.16	5.96	2.55	4.26	5.11	0.00	0.85
placenta, adult, pool1	10021-101D3	67.83	45.90	23.87	14.73	7.53	8.49	6.67	1.83	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	44.10	12.58	7.02	7.95	2.91	1.72	2.25	1.06	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	146.46	37.04	0.16	19.92	7.78	5.29	2.96	0.00	1.25
pons, adult, pool1	10033-101E6	273.44	150.79	323.53	61.97	39.33	41.40	24.70	11.19	1.72
postcentral gyrus, adult, pool1	10032-101E5	119.08	55.97	417.66	32.17	12.47	13.86	11.07	19.53	1.22
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	31.37	0.00	33.46	10.46	16.73	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	16.52	0.00	0.00	0.00	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	78.95	25.49	0.15	15.29	5.68	4.95	2.62	0.00	1.60
prostate cancer cell line:PC-3	10439-106E7	108.54	49.73	0.91	12.89	5.81	3.27	3.45	0.18	1.82
prostate, adult, pool1	10022-101D4	107.47	47.43	23.40	13.88	9.43	5.26	6.26	1.45	0.09
putamen, adult, donor10196	10176-103C5	129.13	132.20	679.63	24.31	5.43	5.67	17.70	18.89	2.60
putamen, adult, donor10252	10152-102I8	107.84	56.86	258.82	9.80	3.92	3.92	3.92	13.73	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	125.67	311.45	5.46	2.19	0.00	6.56	19.67	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	80.94	103.41	522.12	12.32	5.80	5.07	15.46	23.19	4.35
putamen, newborn, donor10223	10365-105F5	99.70	87.71	260.13	10.50	14.24	7.50	19.49	11.24	2.25
rectal cancer cell line:TT1TKB	10469-106I1	39.28	21.53	0.00	6.40	4.95	6.40	4.95	0.00	0.58
rectum, fetal, donor1	10067-101I4	57.03	73.72	8.35	5.56	2.78	8.35	8.35	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	123.60	35.62	2.12	31.38	9.33	7.00	2.33	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	47.63	33.55	0.41	9.53	3.73	0.83	3.31	0.41	1.24
retina, adult, pool1	10030-101E3	65.70	81.31	87.37	8.45	5.27	4.08	13.92	7.55	0.99
retinoblastoma cell line:Y79	10475-106I7	32.22	71.19	1.82	11.17	2.08	2.34	18.97	0.26	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.07	83.85	0.00	10.20	1.97	1.35	9.10	0.00	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	32.06	130.76	0.00	5.91	2.81	3.66	17.43	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	112.92	99.28	0.00	25.01	6.82	10.61	13.64	0.00	1.52
salivary acinar cells, donor1	11771-123I7	180.63	20.56	2.10	19.10	11.01	7.61	0.65	0.00	0.81
salivary acinar cells, donor2	11772-123I8	138.51	12.12	25.61	16.52	6.06	7.44	0.83	1.38	1.10
salivary acinar cells, donor3	11773-123I9	113.87	29.79	19.20	13.90	7.28	6.62	2.65	1.32	1.32
salivary gland, adult, pool1	10093-102C3	141.84	19.45	24.59	10.30	8.01	5.15	0.57	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	180.09	46.54	1.35	43.17	37.01	23.69	3.37	0.17	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	153.29	48.20	0.71	41.03	26.45	20.57	4.47	0.00	1.06
seminal vesicle, adult	10201-103F3	47.09	46.56	32.80	11.64	2.65	4.23	6.88	0.00	6.35
serous adenocarcinoma cell line:JHOS-2	10639-108I9	62.92	26.96	0.49	10.45	3.64	5.34	1.46	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	159.79	33.47	0.75	23.15	9.56	9.31	1.26	0.25	2.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	124.44	36.13	2.01	27.10	15.05	15.05	3.01	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	18.80	33.18	16.52	1.75	1.34	0.27	4.84	1.34	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	65.32	24.76	0.66	12.27	8.62	4.42	2.21	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	74.58	16.52	12.13	16.00	9.29	5.81	1.81	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	23.41	14.90	339.06	4.26	5.67	1.42	2.13	49.65	5.67
skeletal muscle, adult, pool1	10023-101D5	72.08	19.19	196.34	14.39	5.76	4.68	2.16	35.62	0.84
skeletal muscle, fetal, donor1	10066-101I3	41.21	35.18	86.43	8.04	4.02	2.01	6.03	8.04	2.01
skin, adult, donor1	10074-102A2	169.63	27.14	27.14	6.79	6.79	6.79	0.00	6.79	6.79
skin, fetal, donor1	10065-101I2	104.15	43.55	66.91	15.78	10.10	6.94	5.05	6.31	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.69	84.05	0.67	40.02	12.01	9.34	6.34	0.00	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	80.06	109.38	0.00	8.51	3.78	6.62	11.66	0.00	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	35.27	85.58	1.54	8.67	0.96	4.05	17.73	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	75.00	26.70	0.66	21.59	11.04	13.19	3.63	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	44.39	136.08	0.00	4.02	0.32	1.29	25.09	0.16	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	141.86	108.52	0.00	19.61	8.72	7.85	19.61	0.00	1.09
small intestine, adult, pool1	10024-101D6	81.58	37.03	271.49	10.03	5.37	3.46	3.94	28.07	0.84
small intestine, fetal, donor1	10064-101I1	32.19	45.45	93.36	5.16	1.97	1.72	4.18	3.93	2.95
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	78.99	77.96	0.51	21.03	10.26	10.77	8.72	0.00	3.59
smooth muscle, adult, pool1	10048-101G3	123.54	79.60	10.34	11.37	5.69	5.17	6.20	1.03	2.84
somatostatinoma cell line:QGP-1	10781-110G7	101.31	106.14	0.00	21.71	7.77	8.31	9.92	0.00	1.07
spinal cord - adult, donor10196	10181-103D1	182.38	211.51	173.43	13.76	15.83	5.51	21.56	5.05	3.90
spinal cord, adult, donor10252	10159-103A6	232.62	98.57	32.72	11.83	11.43	3.94	13.01	0.39	1.97
spinal cord, adult, donor10258	10369-105F9	138.36	103.77	78.17	1.38	3.46	3.46	4.84	2.08	4.15
spinal cord, fetal, donor1	10056-101H2	88.43	121.97	76.84	21.34	6.71	6.10	14.03	1.22	1.83
spinal cord, newborn, donor10223	10359-105E8	154.30	114.34	51.43	13.78	18.83	11.48	13.32	2.76	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	233.59	57.05	0.15	61.53	15.38	22.85	2.99	0.00	3.44
spleen, adult, pool1	10025-101D7	70.82	43.61	1.65	18.50	9.80	8.59	6.17	0.44	0.22
spleen, fetal, pool1	10044-101F8	56.89	44.97	1.91	10.25	6.52	4.13	6.36	0.24	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	25.15	5.80	0.00	7.97	2.07	2.69	1.04	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	41.01	16.52	0.00	10.44	4.37	4.18	1.14	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	65.00	55.21	19.22	6.99	4.19	2.10	5.94	1.05	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	100.08	56.69	0.00	12.51	7.43	4.30	2.74	0.00	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	61.46	33.77	0.00	7.20	4.61	3.94	3.15	0.00	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	61.85	26.69	0.00	11.01	5.08	3.81	3.81	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	82.50	18.19	0.00	28.77	10.15	10.58	2.96	0.00	0.85
stomach, fetal, donor1	10062-101H8	43.79	63.01	1.07	16.02	1.07	4.27	6.41	0.00	0.00
submaxillary gland, adult	10202-103F4	62.10	32.47	25.64	9.11	3.99	3.42	4.56	2.85	1.14
substantia nigra - adult, donor10196	10178-103C7	379.92	597.02	54.27	0.00	0.00	0.00	0.00	0.00	379.92
substantia nigra, adult, donor10252	10158-103A5	425.80	114.03	24.51	18.90	20.98	6.44	14.75	0.42	3.12
substantia nigra, adult, donor10258	10371-105G2	147.42	165.00	211.04	3.10	4.66	4.14	11.38	5.69	3.62
substantia nigra, newborn, donor10223	10358-105E7	103.87	103.87	28.26	14.13	10.60	9.19	13.42	1.41	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	40.58	40.58	0.00	10.55	3.44	2.29	5.50	0.00	1.15
temporal lobe, adult, pool1	10031-101E4	137.84	52.30	314.07	39.76	15.17	15.34	7.97	20.18	1.78
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	193.02	173.79	0.71	14.25	7.12	9.26	22.08	0.71	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	187.24	192.96	2.64	13.63	6.59	6.59	21.54	0.44	5.27
tenocyte, donor1	11763-123H8	174.90	39.10	0.00	31.07	10.47	9.08	3.49	0.00	0.35
tenocyte, donor2	11765-123I1	159.85	41.97	0.38	15.26	11.06	6.49	2.29	0.00	2.29
tenocyte, donor3	11768-123I4	216.84	17.05	1.11	49.67	18.53	13.71	0.74	0.00	3.34
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	65.43	159.25	0.17	38.58	8.50	15.13	31.95	0.17	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	16.96	73.53	0.00	2.62	1.23	0.77	11.25	0.00	0.77
teratocarcinoma cell line:PA-1	10807-111A6	30.69	84.00	0.00	29.91	4.96	6.97	11.00	0.00	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.29	50.65	0.13	19.80	5.97	8.38	5.59	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	17.02	62.02	0.00	9.45	1.51	5.67	20.04	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.79	25.63	0.76	4.69	2.62	3.49	3.49	0.22	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	6.84	53.09	0.00	6.19	1.95	1.95	11.07	0.00	0.98
testis, adult, pool1	10026-101D8	57.34	47.24	8.48	18.58	11.49	5.15	23.41	0.75	0.54
testis, adult, pool2	10096-102C6	23.91	41.50	4.06	8.57	3.61	3.61	18.49	0.00	3.16
thalamus - adult, donor10196	10168-103B6	167.81	158.97	245.08	12.14	7.73	8.83	24.29	12.14	2.21
thalamus, adult, donor10252	10154-103A1	350.86	129.87	139.72	22.82	20.63	4.69	12.97	5.94	2.34
thalamus, adult, donor10258, tech_rep1	10370-105G1	58.51	260.20	327.94	7.70	7.70	4.62	9.24	20.02	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	102.11	77.90	135.21	25.86	8.23	10.21	8.73	5.93	3.13
thalamus, newborn, donor10223	10366-105F6	75.94	107.58	248.54	54.66	10.93	58.11	13.81	8.63	1.15
throat, adult	10209-103G2	69.66	24.47	158.04	11.73	8.24	4.74	1.75	20.47	0.75
throat, fetal, donor1	10061-101H7	45.40	55.76	96.29	10.06	2.44	2.13	6.40	22.55	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	5.56	26.63	0.00	2.38	0.20	0.79	8.74	0.00	0.40
thymus, adult, pool1	10027-101D9	46.03	50.01	6.86	13.02	6.66	4.57	16.20	0.50	0.20
thymus, fetal, pool1	10043-101F7	50.29	49.56	15.38	12.57	6.13	3.43	13.92	0.94	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	117.01	29.65	0.00	25.53	9.84	9.04	1.99	0.00	2.39
thyroid carcinoma cell line:TCO-1	10783-110G9	81.58	53.50	0.00	11.87	4.05	2.65	4.33	0.00	0.84
thyroid, adult, pool1	10028-101E1	66.72	51.51	20.90	13.62	6.07	4.01	9.14	1.03	0.84
thyroid, fetal, donor1	10060-101H6	50.62	45.09	22.94	5.27	2.90	2.37	3.95	1.32	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	33.88	61.59	12.32	6.16	12.32	0.00	12.32	6.16
tongue, adult	10203-103F5	98.61	23.03	205.13	11.40	8.61	3.72	2.09	26.28	2.09
tongue, fetal, donor1	10059-101H5	63.84	42.17	367.29	9.06	5.91	3.55	3.55	26.40	3.55
tonsil, adult, pool1	10047-101G2	63.51	15.83	22.14	15.03	6.31	5.31	2.70	3.81	0.10
trachea, adult, pool1	10029-101E2	95.95	27.24	19.88	16.20	10.63	5.89	2.13	2.45	0.25
trachea, fetal, donor1	10058-101H4	60.40	33.08	48.86	11.16	2.69	3.85	2.69	6.92	3.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	217.53	75.81	0.00	29.76	17.36	18.07	3.90	0.00	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	89.26	31.81	0.00	20.57	9.83	6.38	4.15	0.00	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	226.88	98.09	0.78	29.14	21.94	16.14	12.85	0.16	1.88
tridermal teratoma cell line:HGRT	10694-109G1	66.59	237.82	0.00	15.22	7.61	9.51	22.83	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	109.54	33.27	27.77	23.79	8.04	5.25	0.68	2.88	1.19
umbilical cord, fetal, donor1	10057-101H3	56.34	52.16	8.35	2.09	4.17	2.09	8.35	0.00	0.00
uterus, adult, pool1	10100-102D1	69.10	77.47	3.24	3.75	2.90	2.73	6.83	0.00	0.51
uterus, fetal, donor1	10055-101H1	52.73	52.73	5.63	7.68	4.61	1.54	4.10	0.00	0.51
vagina, adult	10204-103F6	135.70	51.05	1.29	24.56	13.57	7.11	7.11	0.00	1.29
vein, adult	10191-103E2	81.32	42.09	21.70	16.44	8.33	5.04	5.48	2.19	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	34.71	14.42	0.00	3.74	1.07	1.07	1.60	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "AB015639:21 AK130812:28 BC152425:-37 AB020693:-37 AF148537:-44 AF148538:-44 ENST00000337526.11:-54 NM_020532.5:-54 NM_207520.2:-54 NM_153828.3:-54 BC012619:-54 AK098385:-54 AK129806:-60 AF132047:-82 BC010737:82 AB384033:85 AM393104:85 AM393557:85 AF320999:87 AJ251383:87 AJ251384:87 CU687182:87 BC026788:-89 KJ894399:89 KJ894400:89 BC012335:-99 AK075039:-134 ENST00000317610.11:-147 ENST00000357732.8:-147 AY102277:-147 AY102278:-147 AY102279:-147 AB040462:-147 AB040463:-147 BC016165:-150 BC150182:-151 BC152555:-151 BC068991:-151 ENST00000394611.6:-201 NM_001321860.1:-201 AY123246:-201 ENST00000404909.5:-431 AY123245:-431" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.